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bstract 
C clodextnn chemistry mvo l es non-co alent molecular mteractlons between the 
mteractmg species The majorrty of these interactions are of the host-guest type. I n  the 
present work, UV-VIS spectrophotometry and I H_NMR studies were used to study the 
mteract lOn between amantadine hydrochlonde, acyclovir and their denvatlves with � 
c clodextrin. Addit ional ly, quantificatIOn of amantadine hydroch londe and acyclovir b IH_ 
NMR spectroscopy were carried out. 
ThIS stud IS based on preparmg amantadme hydrochlonde and acyclovir derivatives 
Anthraqumone-2-carboxyl ic aCId and benzoyl chloride were used as denvatlZmg agents for 
amantadine hydrochloride and acyclovir, respectively. Derivatization procedure was based 
on nucleophi l ic displacement by an amino group (amantadine or acyclovir) to the acyl 
carbon I m 2-anthraqumone carbonyl chloride or benzoyl chloride. As a resu lt ,  an amide 
bond was formed between each drug (amantadine hydrochlorid or acyclovir) and 2-
anthraquino ne carbonyl chlonde or benzoyl chloride, respecti ely 
ComplexatIOn in so lut ion wIth �cyclodextrm was evaluated using UV-Vis spectroscopy 
for 2-Anthraquinonyl amantadine ( AqA) and 2-N-benzoyl acyclovir (NBACV). The effect 
of �cyclodextrin concentration as wel l  as the effect of pH was studied The associat ion 
constants (Ka) for the formation of the inclus ion complexes were determmed using the lmear 
Benes l -Hi ldebrand p lots Values of Ka >1 0 8  were obtained ind icating high affinit for 
formmg the mcluslOn complexes between fJ-cyclodextrin and both 2-Anthraquinonyl 
amantadme and 2-N-benzoyl acyclovlf 
1 1  
man tadlne hydrochloflde , 2-An thraqulnonyl aman tadine , acyclovir and 2-N-benzoy l 
ac clo Ir were used as gues t molecules to inves tiga te the inclusion complexa tIon behavIOr 
usmg I H-NMR spec troscopy I n tegra tions of the H-3',5 ',7' pro ton a t  0 2 07 ppm for 
aman tadine, 2-An thraqulnon I aman tadme as wel l  as H-8' a t  0 7  82 ppm for acyclo If and 2-
-benzo l ac c lo Ir were used to calcula te the s tOIchIome tries and forma tIOn cons tan ts for fJ 
c clodex trin inclus ion comple es 
The resul ts showed tha t amantadine hydrochloride and acyclovir exhibI t 1 :  1 
s tOichIOme try wi th ,B-cyclodex trin, while 2-An thraqumonyl aman tadine and 2-N-benzoyl 
ac clovlr exhibi t  1 : 2  s tO ichiome try. The Ka values of 3 . 1 x 1 01 mo ri L I and 4.3 x 1 0 1 mo rl 
L I for aman tadine ,B-cyclodextnn and acyclovir-,B-cyclodex tnn 1: 1  inclUSIon complexes were 
ob ta ined 2-An thraqu inonyl aman tadine ,B-cyclodex trin and 2-N-benzoyl acyclovlr-,B-
c clodex tnn 1.2 inclus ion complexes gave Ka va lues of 3 2 x 1 04 mor2 L 2  and 5 9 x 1 02 mo r 
., '1 
� L �  a t  room tempera ture. 
NMR spec troscopy has been used for quan ti ta tive de termina tion of pharmaceu tical 
compounds m differen t ma trices. This is due to i ts Simplici ty and s traigh tforward evalua tIon 
and m terpre ta tion. O ther advan tag es of NMR are i ts nond estruc tive na ture and selec tiVI ty, 
toge ther wi th the fac t tha t I t  g ives s tructural informa tion abou t o ther con taminan ts tha t  may 
be presen t Furthermore, i t  is fas t, easily performed and almos t no sample prepara tIon or 
sophis tIca ted reagen ts are needed. NMR as a quan ti ta tive spec troscopic tool enabled the 
de termina tIOn of the amoun t of aman tadine hydrochloride and acyclovir an tiviral drugs in 
pharmaceu tIcal and human p lasma samples This me thod was based on using malOnIC aCId 
as an In ternal s tandard. IH_NMR s ignals a t  0 2. 07 ppm for aman tadine hydrochlor tde and 0 
111 
7 82 ppm for ac clo Ir, respec t I ely, were used for calcula tmg the concen tra tlOns of bo th 
drugs In pharmaceu tical and plasma samples. The malomc aCid signal a t  <53 24 ppm was 
used a the reference signal A erage percen t recovenes In the ranges of 97 70-100 40 0' 0 and 
96 1 - 1 03 6 0' 0 were ob tained m pharmaceu tical and plasma samples, r espec tive ly. 
Appl fig the s ta tIS tical tuden t t- test revealed insignifican t difference be tween the real 
and measured con ten ts a t  the 95 % confidence leve l The F- tes t revealed mSlgmfican t 
differences in preC ISion be tween the developed NMR me thod and HPLC me thod for 
anal zing aman tadine hydrochloride and acyclovir 
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1 . 1 .  In trod uction 
Viral infectious diseases are continuing threats to human beings, regardless of age, sex, 
hfestyle, ethnIc background, or socioeconomic status. They cause suffering and death and 
impose a financial burden on society. Fortunately, most viral infections are self limiting [1] 
and vaccines ha e, up to date, occupied the central position in controlling viral disease such 
as Poliomyelitis, Mumps, Measles, Rabies, Smallpox and Influenza. 
Although, there is a steady progress in the development of antiviral therapies, the 
morbidity and mortality caused by hepatitis and herpes viruses and cytomegalovirus in 
immuno-compromised patients are still high. However, the impact of the human immuno­
deficiency viruses (HIV -1 and HIV -2), the causative agent of acquired immunodeficiency 
syndrome (AIDS), in stimulating research is unequalled. AIDS is invariably fatal and the 
presently available treatments are extremely expensive. Therefore, development of drugs 
that are active against viruses is one of the most challenging areas in antimicrobial therapy 
and new bioanalytical methods will be required [1] .  
Amantadine and Acyclovir antiviral drugs have been used for the treatment of influenza 
and herpes virus, respectively. Influenza is one of the oldest and most common viral 
respiratory disease causing significant morbidity and mortality. Compared with most other 
vual respiratory infections, influenza infection often causes a more sever illness such as 
pneumonia and heart disease and can increase the rates of hospitalization and mortality [2] . 
Although influenza vaccine is the primary prevention measure for influenza, antiviral drugs 
are an important adjunct to influenza vaccine for the control and prevention of influenza [3] . 
Four currently antiviral agents are available for the treatment of influenza.: Amantadine, 
Rlmantadme, Zanaml If, and Oseltamlvlf Amantadme and Rtmantadine are used for the 
proph la IS and treatment of mfluenza-A infection, whereas Zanamlvlr and Oseltamivlr are 
neurammldase mhlbltors Wlth activIt agamst both influenza A and B viruses [3,4] 
Amantadme and ItS structural analogue Rimantadine were identified by tradItIonal 
bIOlogIc screenmg assa s m the early 1960s and approved for treating all influenza infectIOns 
in 1976 [4] Amantadme ( l-adamantamine) is used in the form of amantadine hydrochloride 
salt (AMA-H I) with the trade names vlfosol, virofral, symadine or symmetrel [5 ,6] It has a 
charactenstlc 10-carbon rigid tricyclIc saturated ring structure and is a baSIC compound wIth 
pKa = 8-10 because of the primary amino group [7]. 
Amantadme has found wide uses also in treatmg other viral diseases such as Hepatitis, 
Herpes, Herpes Zoster euralgia, Creutzfeldt-Iacob's disease, Born's disease, Influenza B 
and others. Its use m the treatment of Parkinson's disease and other neurological diseases IS 
ery common and very good results were achieved [5,6]. 
On the other hand, acyclovir is a synthetic punne nucleoside analogue 2-amino-1,9-
dlhydro-2-[(2-hydroxyehtoxy)methyl]-purine-6-one [8,9]. It is a white to off-whIte 
crystalline powder with molecular weIght of 225.21 and solubtlity in water below 2 . 5  mg/ml 
at 3rc. Ac clo If pKa values are 2 .27 and 9.25 [8] . 
Acyclovir is used as an antivlfal for the treatment of herpes infection [3,9]. Other 
antlherpetlc drugs include Ganciclovir [4 ,9], DHPG, Idoxuridine, and Trifluridine [10] 
Acyclovlf IS the most Widely used of these antivirals either in its original form (Zovirax) or 
as the pro-drug Valacyclovir (Valtrex) because of its effectiveness against herpes sLmplex 
2 
type-1 and II as well as Varicella Zoster VlfUS [3,11] . It has also been used In the treatment of 
pnmary and recurrent gemtal herpes, herpes simplex encephalitis and neonatal H V Infectlon 
[6] 
1 .2. omenclature and classificati ons 
Anti lfal agents are classified into two categories, nucleoside and non-nucleoside drugs 
ucleostde analogues drugs are used in the management of viral mfections, Including herpes 
simple virus (HSY), human immunodeficiency virus (HIY), hepatitis viruses, HCV, and 
human cytomegalovlfUs (HCMV) infections [1, 13] An example of this group is Acyclovlf 
as shown in Figu re 1 . 1 B. On the other hand, non-nucleoside drugs represent a diverse class 
of structurally uruelated compounds An example of this group is Amantadine hydrochloride 
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Figure 1 . 1 :  Chemical structure of (A) Amantadine hydrochloride; (B) Acyclovlf 
4 
1.3. A na lytical methods for the determi nation of antivi ral d rugs 
Various methods ha e been applied for the determination of trace levels of antiviral drugs 
and their metabolites in pharmaceuticals and in biological matrices and to support in vivo and 
in vitro pharmacokinetic studies [12] . These techniques include: high performance liquid 
chromatography (HPLC) , micellar liquid chromatography, gas chromatography, capillary 
electrophoresis, radioimmunoassay and potentiometry. Most of these techniques were 
devoted to biofluids like whole blood, plasma, serum and/or urine [6] .  
Chromatographic methods (GC and LC) with vanous modes of detection have been 
widely used for the analysis of amantadine in biological samples [ 12J. These methods 
require sample pretreatment extraction and/or derivatization procedure for improving 
detection sensitivity [1,7,14-17]. Early GC methods relied on flame ionization detection 
(FIO) of the underivatized compound, allowed the determination of amantadine in plasma 
and urine samples. However, the detection limits remained high, which would prevent the 
detection of amantadine in more precise pharmacokinetic studies [1,7,15J 
Few spectrophotometric and fluorimetric methods have been reported in the literature for 
the determination of amantadine in pharmaceutical dosage forms. These methods were 
laborious, time consuming, and/or require derivatization of the drug [17,18] . Reported 
methods for the analysis of amantadine in pharmaceutical formulations, such as acid-dye 
spectrophotometry, oscillopolarography, lon selective electrodes and capillary 
isotachophoresis showed less sensitivity and specificity compared to that based on 
fluorimerty [17,19]. 
5 
Immunological methods, reversed-phase high-performance liquid chromatography (RP­
HPLC), radioimmunoassay (RIA) and enzymelinked irnmunoabsorbent assays (EUSA) are 
among the most sensitive methods that have been used to quantify acyclovir in 
pharmaceuticals, pharmacokinetics and optimal dosing. However, these methods have the 
disad antages of being costly, time consuming and their need to develop antiserum or 
monoclonal antibodies [8,12,20,21] .  Additionally, RIA is inconvenient due to the 
manipulation and disposal of radioisotopes [20] . 
Alternatively, RP-HPLC methods have been largely used in the determination of 
acyclovir in biological samples [20]. Liquid chromatography (LC) with ultraviolet (U V) 
detection is the method of choice for the routine determination of acyclovir in biological 
samples since it is a non volatile compound containing several polar functional groups. 
Fluorescence, mass spectroscopic (MS) and electrochemical detection (ED) are other options 
in LC for more specialized applications. Nevertheless GC can offer advantages over LC for 
the determination of acyclovir if higher sensitivity is required. Furthermore, GC-MS is 
particularly useful if higher selectivity is required for the structural determination of 
metabo lites [1] .  
Since acyclovir is a polar compound, derivatization is necessary for its analysis by gas 
chromatography (GC), whereas pre-or post-column derivatizations have rarely been used for 
its analysis by LC. Generally, the nucleosides and their bases are relatively unreactive 
compounds and they are not generally suitable for pre- or post-column chemical modification 
by the reagents commonly used in LC. In addition to their lack of reactivity, these 
compounds tend to contain more than one functional group available for derivatization. 
6 
Thu , tep must be taken to pre ent illcomplete reactIon as well as the productIOn of 
multIple-reactIon products [1 ]. 
1.4. MR for q ua n ti tative a nalysis 
uclear magnetIc resonance spectroscopy (NMR) is one of the most unportant and 
Ide pread analytIcal methods m academic and industrial research [22]. It IS structurally 
speCIfIC and a useful tool for both identification and quantificatIon of the relatIve amount of 
molecular groups of orgamc compounds, thus offering a tool to quantify entire molecular 
tructures e en in mIxtures [22,23] Early research on quantitative nuclear magnetIc 
resonance spectroscopy (qNMR) has been descnbed In the literature in 1 963 by lungnickel 
and Forbes [24], HollIS [25 ] 
A recent reVIew showed the increasing use in International Pharmacopoeias for 
quahtatl e and quantItatIve NMR spectroscopic applicatIOns [26]. 
1 .4. 1 .  QNMR versus other analytical method s  
The main advantages of qNMR analysis are its simplicity and straightforward evaluatIon 
and mtrepretatlOfl. In most applications, the sample only has to be dissolved In a proper 
deuterated solvent and the NMR analysis takes few minutes [26 , 27]. The amount of solvent 
needed IS about 0 7  ml (using common 5 mm probe heads) So, facing the larger solvent 
volume ill HPLC, the higher costs for deuterated solvents are compensated for the small 
volume used [26] . Ideally, every signal in the NMR spectrum is directly proportional to the 
number of resonatmg nucleI that induces the signal This makes the technIque conceptually 
SImple for quantItative analysis [23, 26-28]. 
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Other advantages of NMR are Its nondestructl e nature and selectivity, together with the 
fact that It gIves structural mformatlon about other contammants that may be present 
[22,23,27] Furthermore, It IS very fast, easily performed and almost no sample preparatIon 
or Ophlstlcated reagents are needed [22,23,26,27] ThIs IS In contrary to HPLC where much 
time has to be spent for eqUlhbration of the columns or derivatizatlon of the analyte in the 
case of UV, fluorescence or electrochemical detectIOn [26]. Moreover, the determination of 
dIfferent lmpunties using chromatographic methods requires several different experimental 
condItiOns for analYSIS [28] 
Compared to other analytical methods, qNMR has htgh limit of detection, i.e. a relatively 
large quantity of sample is requlfed. Because orgamc compounds typically generate several 
peaks, the complexity of the spectra, especially for IH_NMR may, also causes problems [23] 
In spIte of the limitatlons lIsted above, there are examples where qNMR is similar m 
sensltl Ity and even more accurate and precise than chromatographic methods [28-31] 
1 .4.2. QNMR method 
Most quantltative NMR methods are based on using an internal standard, for particular 
analyses and impro ement of the results [28]. The ratio of the integral of a spectfic signal of 
the analyte to the integral of a specific signal of the internal standard is employed for the 
quantltattve analysIS [28-30). Preparation of the NMR sample is done by accurately 
weighmg both test and internal standard compounds to ensure high precision and accuracy 
and thIS IS the method currently recommended by the United States Pharmacopoeia (USP) 
[31 ] 
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1 .4.3. election of an appropriate in terna l standard 
The choice of an appropriate internal standard is necessary for the development of a 
qNMR method with wide applicability and good precision. Ideally, the reference compound 
must be highly pure, soluble in the solvent of choice, stable for long time under experimental 
conditions, and it should not react with any of the test compounds. Moreover, it should have 
an intense singlet in a usually signal free region of the NMR spectrum (should not interfere 
with those of the sample). Several compounds have been proposed and each has its own 
characteristic [31]. 
1 .4.4. QNMR applications 
A number of papers describing NMR methods for the quantitative determination of active 
substances in pharmaceutical forms have been reported in literature over the last decade [28-
30] 
Quantitative IH NMR has been applied in determination of the "octane number" in 
gasoline, organic osmolytes and their metabolites in crude plant tissue extracts, the 
intracellular pH and acrylic unsaturation in ultraviolet light curable resins. It has also been 
used to characterize colon tumors, microbial extracts, polyethylene, poly( ethylene glycol)s, 
starches, peroxidation of lipoproteins, characterization of block copolymers and quantitation 
of brain water and cerebral metabolites [32]. 
The use of lH_NMR spectrometry for typical pharmaceutical impurity evaluation has 
been reported in several papers [23,26]. A quantitative method for impurity determination of 
acetaldehyde and propionaldehyde in poloxamer has been reported as well [27]. 
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urve of the sClentwc llterature did not mdicate the use of q MR to quantify 
amantadme and ac clo If anti Ifal drugs in pharmaceutical and biological samples Thus 
de elopmg a rapid specific and selective NMR method for quahtatlve and quantitati e 
anal SIS of ac clo Ir and amantadme IS needed 
1.5. Introd uction to Cyclodextri ns (CD) 
The fir t reference to cyclodextnns was published by Villiers in ] 89], when he studied 
the degradatIOn of starch by the action of Bacillus amy/abaeter [33]. Apart from other 
products, he Isolated small fractions of two crystallme products which were later identified as 
a- and ,B-cyclodextrm. Schardmger in the period 1903-1911, studied their physical 
properties and isolated a new organism called Baeillu maeerans which became the most 
Important source of glycosyl transferase (the enzyme that converts starch into cyclodextrins) 
[34] Because of his pioneering role, cyclodextrins are sometimes called Schardmger 
dextnns The cyclic structure of cyclodextrins was discovered by Freudenberg in ] 938 who 
came to the conclusion that a- and ,B-cyclodextrin are composed of maltose units and contain 
a-I-4 glycosidiC linkages as in starch [35] . French and co-worker discovered that there are 
even larger CDs [36 ,37] 
Later on, It was recognized that cyclodextrins can form mclusion complexes with wide 
vanety of compounds such as organic, inorganic and biological molecules mside their 
caVIties, which made them part of the field of supramoleuclar chemistry [38] . This findmg 
has led to a vast number of papers and books dedicated to the complexation properties of 
cyclodextnns and their appitcatlOns [39] Many new denvatlves were synthesized to modify 
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the complexation behavior and to introduce functionalities like catalytically active centers to 
create enzyme models, both in enzymatic and nonenzymatic reactions [39]. 
The de elopment of cyclodextrin chemistry and technology is reflected by the large 
number of reviews, more than 450, which has appeared on this su bject over time [40]. Each 
ear cyclodextrins are the su bject of almost 1000 research articles and scientific abstracts. In 
addition, numerous inventions have been described (over 1000 patents or patent applications 
in the past 5 years) [38]. 
1.5. 1. Structu re a nd p hysioc hemical properties of cyclodextri ns 
Cyclodextrins (CDs) are cyclic oligosaccharides built up from a-D-glucopyranose 
moieties that are linked by a-l-4 glycosidic bonds. The most common native cyclodextrins 
are a- /3-, and y-cyclodextrin having 6, 7, and 8 glucopyranose moieties in the ring 
respectively ( Figure 1 . 2) . This geometry gives the cyclodextrin the overall shape of a 
truncated cone with the wider side formed by the secondary hydroxy groups (at C-2 and C-3) 
and the narrower side by the primary 6-hydroxyl groups [39,40] ( Figu re 1 .3) . 
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Figure 1 .3: The scheme of stereo-configuration and truncated cone of a-, p-,y-cyclodextrm. 
a-cyclodextrm n = 6, P-cyclodextrm. n = 7; C) y-cyclodextfLn: n = 8 
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Figu re 1 .4: Molecular dimensIOns of a-, p-, and y-cyclodextrms in Angstroms AO 
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The number of glucose units determines the internal diameter and size of the cavity, 
while the height of the CD cavity is the same for all three types ( Figu res 1 .2 and 1 .4). The 
ca ity 1S lined by non-polar methylene groups and the glycosidic oxygen bridges [39,40). As 
a result of this special arrangement of the functional groups in the cyclodextrin molecules, 
the cavity is  relatively hydrophobic while the external face is  hydrophilic [38,39,40). As a 
result of this cavity, cyclodextrins are able to form inclusion complexes with a wide variety 
of hydrophobic guest molecules. In addition, the C-2 OR of one glucopyranose unit can 
form a hydrogen bond with the C-3 OH group of i ts adjacent glucopyranose, resulting in the 
formation of a secondary belt. This renders the structure of cyclodextrin rather rigid [39,40] 
Some of the important physical properties and characteristics of cyclodextrins are listed 
in  Table 1 . 1 . The most characteristic physical property of cyclodextrins is their ability to 
form complexes with a wide range of organic and inorganic compounds by including them 
into their hydrophobic cavities in  the solid state as well as in  solution [38,39). In an aqueous 
solution, the slightly hydrophobic cyclodextrin cavity is occupied by water molecules (polar­
apolar interaction) and therefore, can be substituted by guest molecules which are less polar 
than water. The main driving force of complex formation is the release of enthalpy-rich 
water molecules from the cavity. Water molecules are displaced by more hydrophobic guest 
molecules present in  the solution to attain an apolar-apolar association and decrease of 
cyclodextrin ring strain resulting in  a more stable lower energy state [38-40). These forces, 
however, are not the only ones which contribute to the binding. Other factors, like van der 
Waals, electrostatic interactions and hydrogen bonding interaction have also been invoked to 
play a role. 
1 3  
able 1 . 1  Ph slcal properties of Cl-, fJ - and y -cyclodextnn 
Property a-CD P-CD y-CD 
o of glucose untts 6 7 8 
Emplfical formula C36�OO30 C.nH70035 C4sHso04o 
Molecular weight 972. 85 11 34. 99 1297. 14 
Aqueous solubility 0 0 (M) 14. 5 (0. 1 2 11) 1 . 85 (0. 01 63) 23. 2 (0.1 68) 
MeltlOg pomt °C 275 280 275 
Cavity diameter AO 4 .7 - 5 3 6 - 6.5 7.5 - 8.3 
Height of torus A ° 7.9±0. 1 7.9±0. 1 7. 9 ± 0 1  
Penphery diameter A ° 1 4. 6  ± 0. 4 15.4±0. 4 1 7. 5  ± 0.4 
Inclusion m cyclodextrins exerts an mtense effect on the physicochemical properties of 
the guest molecules as they are temporarily locked or caged within the host cavity givmg nse 
to beneficial modificatIOns of the guest molecule. These properties include' solubility 
enhancement of highly msoluble guests, stabilization of labile guest agamst the degradatlve 
effects of oxidatlon, vIsible or UV light and heat, control of volatility and sublimatIOn, 
physical isolation of lOcompatible compounds, chromatographic separations, taste 
modification by masking off flavors, unpleasant odors, controlled release of drugs and 
flavors [38, 4 1]. 
The potential guest list for molecular encapsulation in CDs is varied and mcludes straight 
or branched cham ahphatics, aldehydes, ketones, alcohols, organic acids, fatty aCids, 
aromatIcs, gases and polar compounds containing halogens, oxyacids and amines. Due to the 
presence of multiple reactive hydroxyl groups on the primary and/or secondary face of the 
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D, man different chemical mOIeties may be mtroduced mto the cyclodextnn molecule b 
reaction Ith these hydroxyl groups. For example, methyl, hydroxypropy� carboxymethy� 
and acet I groups result m the mcrease of CDs functionality and applications [38] 
The ablltt of a CD to form an mcluslOn complex with a guest molecule is a function of 
two ke factors The first IS stenc factor and depends on the relative sIze of the CD to the 
Size of the guest molecule or certam key functional groups within the guest. The second 
factor IS the thermodynam1c interactions between the different components of the system 
(CD, guest, solvent) [38] 
1.5.2. Detection of the b inding process of cyclodextrin complexes 
The two most sigmficant parameters needed to be determined in the study of the 
c c10dextrm mcluslOn complexes are their stoichiometry and formation constants values 
[42,43] Both parameters can be deduced from the experimental data [42]. In genera� 
drfferent methodologies can be used to determine the stoichiometry of the complexes formed 
and thelf formation cOflStants [43] 
The stOlchlOmetry of mclusion complexes can be determined simply by fitting the phase­
solublhty diagrams to the appropriate equation Without further verification. In other cases, 
the stOichiometry of complexation can be verified through Job's plots or nuclear magnetic 
resonance (NMR) studies [43] 
A number of techniques are available for studying the complexation of guest molecules 
mto cyclodextrins. The most powerfu I technique IS NMR, since it gives direct structural 
mformatlOn about the complex formed. Chemical shifts of guest protons and/or shifts of 
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cyclodextrin host protons located inside the cavity (H-3 and H-5) have been used to stud 
the binding process with numerous substrates and confmned that inclusion in the CD cavity 
had taken place [37,40]. Initially, the investigations were only carried out in solution by H­
NMR, but now C-NMR, N-NMR, F-NMR and P-NMR spectroscopic methods all have been 
used for studying the inclusion complex formation. A number of reports on NMR studies in 
the solid state have been published [39]. 
Among the substrates studied by NMR are nitro-substituted aromatics, particularly 
nirophenols , transcinnamic acids, some carboxylates, azo dyes, aromatic amino acids, 
ephedrine, anilinonaphthalene sulfonates, azuiene, adamantanes, nonionic surfuctants, 
menthols and many drug molecules [44]. 
A variety of optical techniques have been applied to study the inclusion of guests into 
cyclodextrin cavities, like UV-Vis, fluorescence and circular dichroism [39,44]. Since 
cyclodextrins are optically transparent, only changes in the optical properties of the guest 
molecules have to be considered. When a chromophoric guest molecule is included in a 
cyclodextrin cavity its absorption coefficient changes and sometimes a shift in the absorption 
maximum is observed [39]. Electrochemical methods like potentiometry, conductometry, 
cyclic voltametry and polarography have proven to be powerful techniques for the 
measurements of the inclusion complex [39]. Other techniques based on isothermal titration 
calorimetry, chromatography, ultrafiltration and freezing point depression were also reported 
[39]. 
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1.5.3. Ind ustrial Application of Cyc lod extrins 
Cyclodextrin' s ability to incorporate a guest within its cavity has found many useful 
applications in a wide range of fields like pharmaceutical industry, agriculture, food and 
environmental protection. CDs and their derivatives have also obtained high attention in 
analytical chemistry especially for the separation of structura� positional and stereoisomers 
of compounds [45]. 
Cyc10dextrins have offered significant advantages in the field of pharmaceuticals .  A 
drug substance has to have a certain level of water solubility to be readily delivered to the 
cellular membrane but it needs to be hydrophobic enough to cross the membrane. One of 
the unique properties of CDs is their ability to enhance drug delivery through biological 
membranes. CDs are water soluble and form inclusion complexes with hydrophobic 
molecules or functional groups in water- insoluble compounds .  The resulting complex hides 
most of the hydrophobic functionality in the interior cavity of the cyc10dextrin while the 
hydrophilic hydroxyl groups on its external surface remain exposed to the environment. The 
net effect is being a water soluble cyclodextrin-drug complex. In addition to improving 
solubility, CDs act as penetration enhancers by increasing drug availability at membrane 
surface thus allowing a reduction in the dose of the drug administration [38]. 
The majority of pharmaceutical active agents do not have sufficient solubility in water 
and traditional formulation systems for insoluble drugs include a combination of organic 
solvents, surfactants, and extreme pH conditions that irritate the stomach, skin or eye or 
cause other adverse reactions. Encapsulation of these incompatible ingredients within the 
cyclodextrin cavity results in the stabilization of the active compounds, reduction in their 
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I rrttanc , maskIng the unpleasant tastes or odors of the drug as wel l  as faCI l itates the handlmg 
of o lat Ile matenals b reducing the Ir o lat i l ity [38 ]  
D have found numerous appl ications m food Industry They form inclusion complexes 
With a anet of molecules mcludmg fats, flavors and colors They are used for the remova l 
and maskIng of unwanted components and for control led release of desIred food constituents 
[4 1 ] Ds are also used In the preparation of cholesterol free products such as mi lk, butter 
and eggs The h drophoblc cholesterol molecule is easily blocked inside cyclodextrin rings 
that are then remo ed, lea mg behmd a " low fat" food. CD-treated matenal shows 80% 
remo al of cho lesterol [4 1 ]  Other applications include reduction of unwanted tastes and 
odour and to stabilization of flavors when subjected to long term storage [38]  
CDs are utilized as a processmg aids in some paint, adhesive and coatmgs processes 
CDs Increase the adhesion properties of some hot melts and adhesives They also make 
addit ives and b lowing agents compat ible with hot melt systems. In some pamt processes, 
po lymers are used to obtain a certam consistency and al low them to adhere to the surface. 
However, they tend to increase v iscosity. Therefore, CDs can be used to oppose the 
undeSIrable effect caused due the interaction between polymer molecules in associat ive 
truckenmg emulsion type coatIngs [38 ]  
CDs play a major role in  envlfonrnental sCience In terms of solubil ization of organic 
contammants as wel l  as enrichment and/or removal of organic pol lutants and heavy metals 
from SO i l, water and the atmosphere. CDs are appl ied in water treatment to mcrease 
encapsu lation and adsorption of contaminants. H ighly tOXIC substances can be removed from 
mdustnal effluent by Inclusion complex formation with CDs C Ds are used to scrub gaseous 
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effluent from organiC chemical 10dustnes The solubdlt enhancement phenomenon of CDs 
IS u ed for test 10g of so t! remediat IOn. CD complexation a lso resulted 10 the increase of 
water olubi l it of three benzimidazo le type fungicides makmg them more avai lable to soi l  
Add it iona l !  , CDs decrease the to ICIty result ing 10 an increase in microbial and plant 
growth, thus the are considered as useful tool for bioremedlation process [38, 4 1 ]  
CDs and their derivat ives have been demonstrated as hosts for the compounds 
respons ible for the unpleasant smel! found in the icinity of water processing p lants They 
were found useful  in the photo-degradation of organophosphorous pesticides in water by 
catal zmg 1Oteractions of pesticides with react ive radicals generated by the photo- sensit izer 
and 1OcluslOn trapped m C D  [4 1 ]  
CDs have been used in the field of chromatographic separations. The use of CDs as a 
separation medium takes p lace from the fact that they can offer a higWy selective system for 
chromatographic separation. For this reason, CDs found therr use to dIfferent iate between 
POSIt iona l  Isomers, functional groups, homologues and enantiomers in al l  current types of 
chromatography [38, 39, 4 1 ]  
C Ds were also extensively used as stationary phases bonded to solid supports or as 
addit ives 10 the carrier system for the separat ion of structural Isomers and structurally related 
compounds In HPLC and capil lary electrophoresis. They have been a lso used m gel 
electrophoresis, capil lary zone electrophoresis, isotachophoresis, capi l lary gas 
chromatography, electrokmetlc chromatography, microdtalys is, Ion exhange 
chromatography, affintty chromatography, thin layer chromatography and separat ion through 
membranes [38,39,4 1 ]  
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Oth r analyt ical appi lcat lons were found ill spectroscopic ana lysis. In  NMR studies the 
can act a chlral agents altenng spectra In electrochemistry, they ha e been used to mask 
contammation compounds a l lowmg more accurate determ1OatlOns [38]  
Co met lc preparation IS  another area in which demands CDs are used, mainly 10 vo lattht 
suppressIOn of perfumes, room fresheners and detergents by control l ing the volat lhty and 
release of fragrances from 1Oclusion compounds. The major benefits of CDs in thIS area are 
stabil Ization, odor control process improvement upon conversion of a l iqUId ingred ient to a 
sohd form, flavor protection and flavor delivery in LIpsticks, water solubi l ity and enhanced 
thermal stabiht of oils. Some of the other appitcatlons of C Ds include thetr use 10 
toothpaste, sk in creams, liqUId and solid fabnc softeners, paper towels, t issues and underarm 
shIelds [4 1 ]  
Text ile fimshmg IS another area in which CDs increasingly attracted the attentIOn. 
Fabncs have been imbued with novel properties by means of C Ds. For example, CDs were 
1Ocorporated to the fabrics to entrap and mask malodors from sweat and cigarette smoke. 
CDs were also used for dY10g fabrics to increase dye uptake by the fabric and reduce the 
amount of dye lost in the wastewater [4 1 ] 
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1 .6 A i ms of the study 
The a uns of the present work are: 
1 .  Study the interaction between each of amantadine hydrochloride and acyclovir 
with P-cyclodextrin using IH_NMR spectroscopy. 
2. Synthesis of 2-Anthraquinonyl amantadine and 2-N-benzoyl acyclovir 
derivatives through optimizing the reaction conditions. 
3. I n  est igat ion of 2-Anthraquinonyl amantadine ,B-cyclodextrin and 2-N­
benzoyl acyclovir ,O-cyclodextrin inclusion complexes in solut ion by UV­
visible spectroscopy. 
4. I nvestigation of 2-Anthraquinonyl amantadine and 2-N-benzoyl acyclovir 
inclusion behavior with ,B-cyclodextrin using IH_NMR spectroscopy. 
5. Development of quantitative IH_NMR methods for determination of 
amantadine hydrochloride and acyclovir ant iviral drugs. 
6. Evaluat ing the rel iabi l ity of the developed IH_NMR method through its 
appl icat ion for the determination of amantadine hydrochloride and acyclovir 
in pharmaceutical and p lasma samples. 
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CHAPTER II  
MATERIALS AND 
. METHODS 
2.  E peri mental part 
2. 1. M aterial a nd i ns tru mentation 
Amantadine hydrochlonde (99 9° 0) was purchased from S igma-Aldrich. Ac c10vlr 
was kmdl gl en from J ulphar Pharmaceutical Co. (UAE) ,B-cyclodextnn and Malomc 
ACid (9�,0) were obtained from S igma-Aldrich and used as received. Phosphate buffer 
solutIOn was used to control the pH of the media. Methanol, d ichloroethane, oxylyl 
chloflde and pYfldme (a l l  H PLC grade) were obtained from S igma-Aldrich and were used 
as recel ed Tfleht lamme (TEA) and dlmethylsu lfo Ide-d6 (DMSO-�) (99 99%) were 
purchased from S igma-Aldrich 
Benzoyl chloflde and anthraqumone-2-carboxyl ic acid were purchased from S igma­
Aldflc� Commercial ly available pharmaceutical dosage forms of Adamme capsules 
(Rameda Co for Pharmaceutical I ndustries and Diagnostic Reagents, 6th October, Carro, 
Egypt ) contalnmg 1 00 mg of amantaidne hydrochloride per capsule were obtained from 
local markets Commercial ly available pharmaceutical dosage forms of Zovirax tablets 
containing 400 mg of acyclovir per tablet were obtained from local markets as wel l  
RJ-45 d iode array s ingle beam UV-Vis spectrophotometer (Agil lent Technolog ies, 
Austria) matched with 1 cm quartz or Sil ica cel ls  was used for al l  UV-VIS absorption 
measurements The IR spectra were measured using a Thermo N icolet NEXUS-470 FT­
I R  spectrometer pH-meter measurements were made uSing Orion Research 40 1 -plus pH 
meter supported with Orion glass  electrode for pH adjustment. Preparative thin layer 
chromatography was performed on Whatman s i l ica gel 60 F254 0 250 mrn plates. The I H_ 
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NMR measurements were carried out using a Varian 200 MHz and Mercury-200 NMR 
spectrometer operating at a magnetic field strength of 4 .7  T. 
2.2. Standa rd sol u tions 
2.2. 1 .  Phosphate buffer solutions 
Phosphate buffer (0 . 1 M) was prepared by disso lving 1 5 .6  g of sodium dihydrogen 
phosphate in 1 l iter water. The solution was adjusted to pH 6.0 to 1 0. 5  by adding NaOH. 
2.2.2. Stock standard solutions 
2-Anthraquinonyl amantadine standard solution ( 1 0'3 M) was prepared by disso lving 
accurately weighed 3 . 85 mg 2-Anthraquinonyl amantadine into methanol This solut ion 
was diluted in methanol to obtain appropriate working standard solut ions at a 
concentration of 1 0-4 M 
A stock standard solut ion of 2-N-benzoyl acyclovir ( 1 0'3 M) was prepared by 
dissolving 3 .29 rng of 2-N-benzoyl acyclovir in methanol and transferred into a 1 0  mL 
vo lumetric flask. Working standard solutions were prepared by further dilut ing the stock 
standard solut ion with methanol to a concentration of 1 0-4 M. 
�cyclodextrin ( 1 004 M) standard stock solution was prepared by d isso lving 567 mg of 
�cyclodextrin in 50 mL deionized water. The solution was di luted with water to 1 00 mL 
in a 1 00 rnL standard flask. �cyclodextrin ( 1 0'4 M) solut ion was used for determining 
the properties of the inclusion complexes. 
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2.3. Proced ure 
2.3. 1 .  ynthe is of  2-Anth raquinonyl amantadine (AqA) 
Anthraqumone-2-carboxyhc acid (0 50 g ,  2 mmol  ) was suspended in oxalyl chlonde 
( 1 0  mL, 1 1 5 mmol). The react Ion mixture was heated under strrring for 3 hrs. A clear 
solutIOn was obtained The excess of oxalyl chloride was removed under reduced 
pressure and the result ing yel low precipitate was dried and dissolved in dichloroethane 
( 1 0  mL) 
To a uspenSlOn of amantadme hydrochloride (0. 1 8  g, 1 mmo l) in dichloroethane ( 1 0  
ml)  three portIOns of triethylamme ( TEA) ( 3  x 0 4  mL) were added to produce a clear 
solutIon To the abo e mixture, anthrquinone-2-carbonyl chloride (0. 54 g, 2 mmol)  was 
added dropwise with strrrmg at room temperature for 2 days. The reactton was 
mon Itored by TLC, e luent (hexane: heptane, 1 ' 1 ;  v/v) 
The solut ion was then evaporated to dryness. The residue was st irred at room 
temperature for 30 min in 50 mL water. Fi ltration gave 0. 5 g of the desired product as a 
whIte so lId 
2.3.2. Synthesis of 2-N-benzoyl acyclovir 
Acyclovir (0 25 g, 1 . 0 mmol)  dried three times by evaporation of pyridine was 
suspended In dry pyridine ( 50 mL). To the above solut ion tr irnethylchorost lane (0 64 
mL, 5 0  mmol) was added. The mixture was stirred for I S  mmutes at room temperature 
Benzoyl chlonde (0 58 mL, 5 .0  mmo!)  was added drop wIse and the reaction mixture was 
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stlITed at room temperature for 2 hrs. The reaction was monitored by TLC ( hexane: 
heptane, 1 :  1 ) . The mixture was then cooled in an ice bath and water ( 1 0  mL) was added. 
After 5 minutes 29 % aqueous ammonia (20 mL) was added and the mixture was st irred 
at room temperature for 30 min. The excess so lvent was then evaporated to near dryness 
and the residue was dissolved in 1 50 mL of water. The so lution was washed once with a 
50 mL portion ethyl acetate. Crystal l ization began immed iately after cooling the aqueous 
layer [46] . A 30. 39 % yield of 2-N-benzoyl acyclovir was obtained. 
2.3.3. UV-Vis Stud ies 
2. 3. 3. 1 .  Effect afpH 
An al iquot of 1 . 0 mL of the 2-Anthraquinonyl amantadine stock solution ( 1 0-4 M) 
was transferred into a 1 0. 0  mL standard flask, 2.0 mL of 1 0-4 M ,B-cyclodextrin and 2.0 
mL phosphate buffer solutions in the pH range of 6.0- 1 1 .  0 were added. The mixed 
solution was di luted to the fina l volume with dist i l led water and mixed wel l .  
Portion of 0. 5 mL of 2-N-benzoyl  acyclovir ( 1 0-4 M) was transferred into a 1 0  mL 
standard measuring flask. To the above solut ion, l . 0 mL ,B-cyclodextrin ( 1 0-4 M) and 
phosphate buffer solution in the pH range of 6.0- 1 1 . 0 (2 .0 mL) were added sequent ia lly, 
di luted to the mark with water and mixed wel l  to give a final concentration of 0. 5 x 1 0-5 
M for 2-N-benzoyl acyclovir, 
Al l  measurements of absorption were made in a 1 cm quartz cel l  against a blank 
solution treated in the same way but without the drug (at Amax= 260 nm for 2-
Anthraquinonyl amantadine and at Amax= 23 5 nm for 2-N-benzoyl acyclovir). 
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2. 3. 3. 2. Ef ect of ,B-cyclodextrin on abs01ption spectra of2-Anthraquinonyl amantadine 
To 2.0 mL portions of 1 04 M 2- Anthraquinonyl amantadine , 0 .0-6. 0 mL portions of 
1 0-1 M ,B-cyclodextrin were added fol lowed by 2. 0 mL phosphate buffer with pH 8. 
So lutions were made up to 1 0  mL in vo lumetric flasks and surged for 5 minutes in 
ultrasonic bath. The absorption spectra of 2-Anthraquinonyl amantadine ,B-cyclodextrin 
inclusion complexes were recorded against b lank containing the same amount of ,B-
cyclodextrin but without 2-Anthraquinonyl amantadine at Amax= 260 nrn. 
2. 3. 3. 3. Ef ect oj ,B-cyclodextrin on absorption spectra oj2-N-benzoyl acyclovir 
Portion of 0. 5 mL of 2-N-benzoyl acyclovir ( 1 0-4 M) was transferred into 1 0  mL 
volumetric flasks. ,B-cyclodextrin 1 0-4 M (0. 0-3.0 mL) was added fo l lowed by phosphate 
buffer with pH 8 (2.0 mL). The solut ions were made up to the mark with dist i l led water 
and surged for 5 minutes in u ltrasonic bath. The absorption spectra of 2-N-benzoyl 
acyclovir-,B-cyclodextrin inclusion complexes were recorded against blank contain ing the 
same amount of ,B-cyc1odextrin but without 2-N-benzoyl acyclovir at Amax= 235 nrn. 
2.3.4. I H-NMR. Stud ies 
2. 3. 4. 1 .  NMR measurements 
I H_NMR spectra of pure drugs, capsules and p lasma's extracts were measured using a 
Mercury 200 MHz, Varian FT -NMR spectrometer operating at field strength of 6. 65 T. 
Typical ly, 200 free induct ion decays ( FI Ds) were col lected for each sample into 1 2, 766 




dl Ided b 320 1 Hz  representing 3 983 pomtslHz and acquIsition tIme of 1 99 1 s were 
used A dela t Ime of l O s between pulses was used to fully ensure TJ relaxation of 
h drogen atoms Chemica l  shtfts were referenced mternal ly to tetramethylsl lane (TMS, 0 
= 0.0) .  The MR probe was maintained at a temperature of 25 °C throughout al l  
measurements Manual mtegrat lon for selected s ignals was adopted for all 
mea urements 
_ . 3. -1. 2. Effect of �cy lodexmn on inclUSIOn complexe 
anous weIghed amounts of �cyclodextrin ( 8  0-52 .0 mg), ( 5 .0-40.0 mg), ( 5 .0-33 1 0  
mg) and ( 1 0  0-8 1 .  0 mg) were dissolved m dist I l led water After that, constant amount of 
amantadine hydrochlonde, 2-Anthraquinonyl  amantadine, acyclovir and 2-N-benzoyl 
ac c lo ir ( 7. 1 ,  5 .0, 5 . 0, 1 0. 0  mg), respectively, were dissolved in methanol .  Then � 
cyclodextrin solutions were poured into the drug solut ions The above mixed so lutions 
were contmuously st irred at 50 °C. After evaporating using rotary evaporator the solutIon 
to dryness, powder product was obtained at different molar ratios. These are so lid 
inclUSion complexes of amantadine hydrochloride, 2-Anthraquinonyl amantadme, 
acyclo ir and 2- -benzoyl acyclOVir with �cyclodextrm 
Al l  products of the Inclusion complexes were d isso lved m DMSO-d6 and thetr IH_ 
NMR spectra were recorded. 
2. 3. 4.3. Cahbration curves 
I n  standard NMR tubes, accurately weighed amounts of pure amantadme 
hydrochloride ( 0 7- 1 5  3 mg) or acyclovir (0. 4-50 mg) were thoroughly mlxed with 1 0. 0  
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mg of ma lonic acid in 0.6 mL of DMSO-d6 each. The so lutions were shaken wel l  unt i l l  
complete d isso lution and their l H_NMR spectra were recorded. I ntegrations of the 
amantadine hydrochloride H-3', 5',7' and acyclovir H-8 signals at 0 2.07 ppm and 7.82 
ppm, respecti ely, were plotted versus drug amounts for the calibration curves. 
_ . 3. .1 . -1. A nalysis of pharmaceutical preparations 
Five capsules of Adamine or three tablets of Zovirax were weighed, ftnely grinded 
and homogenized in a mortor. Powder portion equiva lents to 6.06, 7 .43, and 8 .03 mg of 
amantadine hydrochloride or 5 . 40, 9. 1 8  and 1 5 . 29 mg of acyclovir were weighed and 
transferred to the NMR tubes. 1 0  mg of malorric acid in 0.6 mL of DMSO-� was added 
to each tube and the mixture was shaken wel l to completely d isso lve the solid powder. 
The l H-NMR spectra were recorded under the experimental conditions given above. 
2.3. 4.5. A nalysis ofplasma samples 
The extraction of a mantadine hydrochloride and acyclovir was done according to the 
method proposed by Bahrarrri et. al . [47] .  To 1 .0 mL plasma sample, 5 .3 ,  1 0. 1  mg of 
amantadine hydrochloride and 5 . 1 ,  1 3 . 1 5  mg of acyclovir were dissolved in methano l and 
1 0  rnL dichloromethane-isopropyl alcohol ( 1 : 1 ,  v/v) were added. The sample was then 
homogenized for 30 s on a vortex mixer and centrifuged at 6000 g for 5 min at 4 0c. The 
supernatant layer was then evaporated to dryness. The residue was reconstituted in 
water, ft ltered and the filtrate was evaporated to dryness. The sample were subjected to 
analys is. 
28 
CHAPTER I I I  
RESULTS AND 
DISCUSSION 
3. Re ult and Discu SlOn 
3. 1 .  y n the of 2-A nthraquinonyl amantadine 
The yntheslS of 2-Anthraqumonyl amantadine was earned out m two steps The ftrst 
tep, anthraqunione-2-carboxyl tc aCid was activated to anthraquinone-2-earbonyl 
chlonde b the act ion of either thionyl chlonde ( SOCh) or an oxa lyl chloride (COClh 
Oxal I chlonde was found to be the most effect l e reagent in convert ing the earboxyltc 
aCid mto the correspondmg aCid chloride. In step (2), the key mtermedlate 2-
anthraqumo nyl chlonde once generated was reacted In slfue with amantadine ammo 
group under nucleophi l ic addit IOn-el imination mechanism ( Figu re 3. 1 )[48] to substItute 
the chlorme atom and to give the desired product ( Figu re 3.2)  
Tneth lamine with  the formula (CH2CH3h, commonly abbreviated Et3 , was 
emplo ed as base in the reaction mIxture to neutralize the amantadine hydrochloride and 
to remo e the h drogen chloride formed during the reaction. React ion of triethylamine 
with hydrogen chloride leads to the production of triethylamine hydrochloride sa lt 
( trtethylammonIum chloride) which was removed by water 
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Figure 3.2. ynthesis of 2-Anthraqumonyl amantadine 
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3.2. ba racteriza tion of 2-A ntbraq uinonyl ama n tadine 
3.2. 1 .  lnf.'a-red pectru m  of 2-Anthraquinonyl amantad ine 
The obtamed product, 2-Anthraqumonyl amantadme, was characterized by infra-red 
spectroscop The FT-IR spectrum of 2- Anthraqumonyl amantadine IS shown in Figu roe 
3.3. The amide -H band appears around 3282 cm-! with medium absorption mtenslty 
The C-H stretchmg absorption of the aromatic ring vibrations are found at 3050 cm-! 
The a l tphat lc C-H stretchmg d ISplay mult ip let splittings in the region of 3000--2800 cm-) 
The carbonyl stretching of amide (NHCO) was observed at 1 675 cm-! . The C=C S igna l  
o f  the aromatic rmg appeared at 1 592 cm-! . The presence o f  some functional groups such 
as -H and the aromatic ring m the infra-red spectra revealed that 2-Anthraquinonyl 
arnantadme IS obtamed 
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3.2.2. uclear magnet ic .'esonance pectru m of 2-Anthraquinonyl amantadine 
The tructure of the obta lOed 2-AnthraqulOonyl amantadme was confirmed by nuclear 
magnetic resonance spectroscopy CH-NMR) 1 The H-NMR spectrum of 2-
nthraqulOon I amantadme IS shown 10 Figu re 3.4. The sharp smglet s igna l  at 8 8. 53 
ppm can be assigned to the H- } '  proton, whi le the H-3'  and H-4' of the anthraquinone 
protons can be attnbuted to the multiplet s ignal at 8 7  95 ppm. The antraqumone protons 
H-Y,6',7' and 8 '  appeared as tnplet at 8 8 20 ppm (1=6 8 Hz) The al iphatic protons of 
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Figure 3.4. IH_NMR spectrum of2-Anthraquinonyl amantadine in DMSO-d6 
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3.3. y n the of 2- -benzoy l acyclovir  
The ynthesls of  2- -benzo I acyclovlI was carried out by a sequential approach. 
The s nthesl process 10 01 es select! e protection of the hydroxyl group of ac c lovtr 
with fer/-but ldlmeth Is ilyl chlortde ( TBM -CI )  prior the N-acylat lon react lon. This 
proces IS referred to as "TM - Transient protection" [46] .  Acyclovir is dispersed 10 
pyrtdme anhydrous . The O-acylated acyclovir in the reactlOn mixture of step ( 1 )  was 
used without ISolation to react with a benzoyl chloride to form an N-benzoyl acyclovlf. 
The rea t lon mixture IS momtored by TLC to ensure completion of the reactlOn to the 
final -benzol ated product. The benzoylation reactlOn is completed within 2 hrs at 
room temperature. The deprotect lon reaction is conducted at low temperature (0 °C) and 
quenched with water and 29 % aqueous ammonia .  Final ly, the N-protected nucleosides 
are obtamed and re-crystal l tzed from water to yields of 3 3  %; m. p = 1 98 - 200 °C ( Figure 
3.5) 
The benzoylation react ion of ammo group ( step 2) produced benzoic aCid as a 
byproduct The acid produced by this reaction is neutralized using concentrated aqueous 
ammoma as an acid scavenger, which forms a water soluble salt. Aqueous ammoma a lso 
causes removal of the tributyldimethylsilyl group. The mechanism pathway IS shown 1 0  
Figu re 3.6 
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o 
l .  TBMS-Cl 
2. Benzoyl chlonde 
3 hydrolysis 
o 
TBMS-Cl = tert-buty ldi methyls i ly l  chloride 






TBMS-Cl = tert-buty ldImethylsllyl chloride 
Figu re 3.6. Mechanist Ic pathway for 2-N-benzoyl acyclovir 
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3.4. ha racteriza tion of 2-N-benzoyl acyclov ir 
3.4. 1 .  Infra-red spectrum of 2-N-benzoyl acyclovi." 
The obtained 2- -benzo I acyclo If was charactenzed by mfra-red spectroscop 
( FigUl"e 3.7) The mfra-red spectra of the 2-N-benzoyl acyclovir showed a broad band in 
the regIon of 3200-3650 cm- 1 corresponding to O-H stretching. The peak centered at 
3 1 9 1 cm- I may be attributed to -H amide stretching. The peak in the range of 2850-
3000 cm-1 IS characteristic of ahphatlC C-H stretching. The signal  at 1 697 cm-I is due to 
C=O stretchmg ibrat lOn. The C=C stretching of the aromatic r ing showed several 
absorpt IOns between 1 450  and 1 600 cm-1 The C-O-C stretching absorption of ether was 
detected m the region of 1 000- 1 1 00 cm- I . The presence of amide stretching and C=C 
stretchmg m the mfra-red spectra mdlcated that 2-N-benzoyl acyclovir was formed and 
the benzo lat lon reaction takes p lace towards the exocychc ammo group of acyclovIr. 
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3.4.2. uclea r magnetic r·e onance s pectrum of 2-N-benzoy l acyclov ir 
The tructure of the obtatned 2-N-benzoyl acyclo Ir was confirmed by nuclear 
magnetic re onance spectro cop e H-NMR). Figur·e 3.8 shows the IH_NMR spectra of 
the 2- -benzo I ac clo If. The amide NH appears as smglet at 5 1 2 .36 ppm The NH 
proton of the punne ring is centered at 5 1 2 .02 ppm as broad smglet. The protons of the 
phen 1 group are resonatmg at 7 60-8.05 ppm as a multiplet The H-IO' of the [ (2-
h dro -ethoxy) methyl ]  appeared at 5 5.52 (s), while H-l l ', and H- 1 2' protons appeared 
at 5 3 49 (d, 2 H, J=8.2 Hz) 
4 1  
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3.5. tudy of inclu ion com plexes of amantadine hyd rochloride and 
acyclovir  derivatives with ,B-cyclodextrin 
3.5. 1 .  Abso .'ption s pectra of ,B-cyclode trin inclusion com plexes 
Figure 3.9 shows the absorptIOn spectra 2-Anthraqumonyl amantadine and 11S 
mcluslOl1 complex. ,B-cyclodextnn has no absorption bands in the UV-Vis range of 200-
800 nm 2-Anthraqu inonyl amantadme shows two absorption bands at 260 and 330 nm.  
The absorptIOn at 260 run appeared as  sharp band with an E value of 8 . 1 7  1 03 whereas 
the absorptIOn at 330 nm is broad WIth an E value of 3 3 8  x 1 03 
Figure 3. 1 0  shows the absorption spectra of 2-N-benzoyl acyclovir and its inclusIOn 
complex 2- -benzoyl-acyclovir shows three broad absorption bands at 235 , 260 and 290 
nm WIth E values of l .04 x 1 04, 9. 1 7  1 03 and 7 .95 1 03, respectively. 
Upon forming the inclusIOn complex of both compounds, intensities of 2-
Anthraqumonyl amantadine (at Amax=260 nm) and 2-N-benzoyl acyclovir (at Amax=23 5 
run) absorption were increased by 27 % and 1 6.8 %, respectively. No changes in !..max of 
absorptIon were observed m both cases This indicates of the formatIOn of the mcluslOn 
complexes between both derivatlZed drugs and ,B-cyclodextrin.  
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Figure 3.9. AbsorptlOn spectra of: ( 1 )  ,B-cyclodextrin; (2) 2-Anthraquinonyl amantadllle, 
( 3 )  2-Anthraqulllonyl amantadllle ,B-cyclodextrin inclusion complex at pH 8, T=25 °C 
The concentratlOn of ,B-cyclodextrin ·  4 x 1 0-5 M and concentration of 2-Anthraquinonyl 
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Figure 3. 1 0  Absorption spectra of: ( 1 ) ,8-cyclodextrin ;  (2)  2-N-benzoyl acyclovir, (3 ) 2-
-benzoyl acyclOVir ,8-cyclodextrin inclusiOn at pH 8, T=25 0c. The concentration of ,8-
cyclodextnn I x 1 0-4 M and concentratlOn of 2-N-benzoyl acyclovir: 5 x 1 0-5 M 
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3.5.2. Effect of p H  
The effect o f  p H  o n  the complexation o f  both denvatlzed drugs with ,B-cyclodextrin 
was e amIned In the pH range of pH = 6-1 1 .  The resulting absorbance-pH plots of both 
inclus ion comple es are shown I n  Figures 3 . 1 1 and 3. 1 2  
pon formmg the InclusIOn complex of 2-Anthraqu Inonyl amantadIne Wlth ,B­
c clodextnn, the absorption Intensity of the inclusion complex at 259 nm Increased when 
pH Increased from 6-1 1 While at pH=7, the absorbance Intensity decreased of the 2-
Anthraqumonyl amantadine ,B-cyclodextrin InclusIOn complex 
The absorbance Intensity of the 2-N-benzoyl acyc lovir ,B-cyclodextrin mcluslon 
complex changed with pH at 235 nm, 260 nm and 290 nm. When pH was increased, the 
absorbance IntenSities of the mcluslOn complex increased. At pH = 1 0 . 5 ,  the absorbance 
at A = 235 nm Increased, wht le the absorbance decreased and shifted to h igher 
wavelengths at A = 260 nm and 290 nm. Thus, pH 8 was selected for further 
mvesttgatlOn 
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Figure 3 . 1 1 .  Absorption spectra of 2-Anthraquinonyl amantadine ,B-cyclodextrin 
inclus IOn complex at different pHs .  From l ine 1 to 4, pH values are 1 0. 5 ,  8 ,  6 ,  and 7, 
respectively ( 5 )  Absorption spectrum of 2-Anthraquinonyl amantadine: 1 x 1 0-5 M. (6) 
AbsorptIOn spectrum of,B- cyc\odextrin .  2 x 1 0-5 M. 
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220 240 260 280 300 320 340 360 
Figure 3. 1 2. Absorption spectra of 2-N-benzoyl acyclovir f3-cyclodextrin inclusion 
complex at different pHs. From I me 1 to 4,  pH values are 1 0.5 ,  8, 7, and 6, respectively. 
( 5 )  AbsorptIOn spectrum of 2-N-benzoyl acyclovIr : 0 .5 x 1 0-5 M (6) Absorption spectrum 
of f3-CD I x 1 0-5 M. 
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3.5.3. Determination of formation constants of 2-Anthraquinonyl amantadine and 2-
N-benzoyl acyclovir ,B-cyclodextrin inclusion com pie 
The tnfl uence of �c c lode tnn on the absorption of both denvatized compounds was 
tudled b keeping the 2-Anthraqutnonyl amantadine and 2-N-benzoyl acyclOVir 
concentratIOns constant at 2 x 1 0-5 M and 0. 5 x 1 0-5 M, respective ly, and varymg the � 
cyclodextnn concentratIOn from 0-4 x 1 0-5 M and from 0-3 x 1 0-5 M, respectively. 
Figures 3 . 1 3  and 3. 1 4  show the absorption spectra of the fonned inclusion complexes 
where the absorptIOn tntenslt les Increase With increasmg �cyclodextrin concentratIOns. 
Increasing absorption intensity at Amax of 259 run and 235 nm for 2-Anthraqutnonyl 
amantadine and 2-N-benzoyl acyclOVir, respectively indicate the fonnation of mcluslOn 
comple between both denvatized compounds and �cyclodextrin . These two 
wavelengths were selected for calcu latIng the fonnation constants of the fonned inclUSIOn 
complexes 
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Figure 3. 13 .  Absorption spectra of 2-Anthraquinonyl amantadine with vanous 
concentratIon of ,B-cyclodextrin at pH 8, T=25 0c. ,B-cyclodextrin concentration from 
Lllle 2 to 7 are' 0; 1 x 1 0-5; 1 5 x 1 0-5 ; 2 x 1 0-5 ; 3 x 1 0-5 ; and 4 x 1 O-5M, respectively. 2-







220 240 260 280 300 320 340 360 
Figure 3. 1 4. Absorption spectra of 2-N-benzoyl acyclovir with vanous concentratIOn of 
� cyclodextnn at pH 8, T=25 0c. �cyclodextrin concentration from Lines 2 to 7 are. 0, 
0 5  x 1 0-5 ; 0 75 x 1 0-5 ; 1 x 1 0-5 ; 1 . 5 x 1 0-5 ; and 3 x 1 0-5M, respectively. 2-N-benzoyl 
acyclovir concentratIOn is. 0. 5 x 1 0-5 M. Line 1 :  �cyclodextrlO, 1 x 1 0-5 M. 
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The mclu Ion formatIOn constant (Kr) is a measure of the complexmg capacity of � 
c c10de tnn Figu re 3. 1 5A and 3. 1 5B show the structural geometry of both molecules 
Two term mal groups on each side of both molecu les can theoretIcally be engaged m 
comple formation leadmg to 1 -2 mcluslOn comple es_ Thus, formatIOn constants of 2-
Anthraqumon I amantadme and 2- -benzoyl acyclovir Wlth �cyclodextnn were 
e aluated assuming a 1 -2 mcluslOn model based on the Benesl-Hlldebrand equation [49] , 
1 
------------- + ----------- ( 1 )  
A - �  (A - Ax,) Kf [CD] 2 (A - Ax, ) 
where [CD] IS the �c c lodextrin molar concentration, � is the absorbance of either 2-
Anthraqumonyl amantadine or 2-N-benzoyl acyclovir in the absence of cyclodextrin, AI> 
IS the absorbance when a l l  2-Anthraquinonyl amantadine or 2-N-benzoyl acyclovlf 
molecules are completely complexed with �cyclodextrin ,  A IS the observed absorbance 
after each [CD] addition and Kr IS the inclusion complex formation constant. A plot of 1 1  
(A-�) versus 1 I�CD]2 shou ld result in a l inear plot if the respective stoich iometry of 
the complex IS  1 2_ Linear p lots were obtained suggesting that both 2-Anthraquinonyl 
amantadme �cyclodextrin and 2-N-benzoyl acyclOVir �cyclodextrin inclUS IOn 
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Figure 3 . 1 6. Double reciprocal plot for: (A)  2-Anthraquinonyl amantadine � 
cyclodextnn mcluslOn complex;  (B) 2-N-benzoyl acyclovir � cyclodextrin inclusion 
complex 
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The formatIon constants (Ka) for the formatIon of the inc lusIOn complexes were 
determtned from the rabo of the Lntercept to slope m the lmear Benesl-Hl ldebrand plots 
The formatIon constants of the J3-cyclodextrin mclustQn complexes are hsted m Table 
3 . 1  alue of Ka > 1 08 tnd Lcate h Lgh affintty for formtng the mcluslOn complexes 
between J3-c clode tnn and both 2-Anthraqumonyl amantadine and 2-N-benzoyl 
acyclo Ir 
55 
Table 3. 1 .  FormatlOn constants of the ,B-cyclodextrin incluslOn complexes Wlth 2-
Anthraqumon I amantad me and 2-N-benzoyl acyclovIr 
Parameter 
FormatlOn constant (Ka) 
CorrelatlOn coefficIent (R2) 










0 .99 1 
y = 9. 53E-9 X + 4 .55E+00 
3.6. Qual i tative MR tud ie 
I H_ MR spectroscopy has pro ed to be useful to study cyclodextnn IncluslOn 
comple e Therefore, further studIes for the inclus ion of 2-Anthraquinonyl amantadme 
and 2- -benzo I ac clovir Wlth ,B-cyclodextrin were performed using I H-NMR 
spectro cop General !  , al l  the guest's protons and not only those that enter the ,B-
c clodextnn ca Ity might show chemIcal shift changes upon complexatIOn With 
c clodextnns. Thus, mformatIOn obtamed from NMR spectroscopy rehes on the study of 
the chemIcal shift d Isplacements of I H_NMR spectral Signals of the guest and host 
protons [50] In our study, the chemical shifts for all protons were recorded and 
differences in chemical shift (66) upon the inclUSion complex formation were calculated 
3.6. 1 .  IH_NMR s tudy of a mantadine ,B-cyclodextrin inclusion complex 
Upon formatIOn of the mclusion complex, significant changes in chemical shIfts of 
some protons ' signals were observed by comparing the spectra of the inclusion comp lex 
Wlth those of amantadine and ,B-cyclodextnn. 
The resonance assignment of amantadine protons is shown in the IH_NMR spectra of 
amantadme ( Figure 3. 1 7  A). The spectrum is wel l  resolved with four types of protons 
three SInglets and one mu ltiplet .  The assignments of amantadIne peaks are as fol lows' 
the broad SInglet signal at 8 8. 1 7  ppm is attributed to the NH2 protons. The H-3',5 ',7 '  and 
H-2',8 ', 1 0' appear as sharp S Inglet at 8 2.06 ppm and 8 1  80 ppm, respectively, whi le the 
H-4',6 ',9' resonates as a multIplet at 8 1 .60 ppm. 
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The ' H-NMR spectrum of ,B-cyclodextnn ( Figure 3. 1 7C) conSISts of five types of 
R sIgnal the H- I signal appears as a smglet at 0 4 82 ppm, while the H-3 and H-6,6' 
signal sho harp smglets at 0 3  64 ppm The H-5 signal appears as a multiplet at 0 
3 6 ppm The H-4 s ignal resonates as a muluplet at 0 3  43 ppm whi le the H-2 multiplet 
appears at 0 3 29 ppm These values are very close to those previously reported by 
chnelder et al [ 50] 
The IH-NMR spectrum of amantadine ,B-cyclodextnn inclusion complex is shown m 
Figure 3. 1 7 B. InclUSIOn of amantadine within ,B-cyclodextrin causes a downfield shift of 
about 0 == 0.04 ppm and /::..0 == 0 05 ppm for the H-3 ',5 ',7' and H-4',6',9' amantadme 
protons, respectively The chemIcal shift of H-2 ',8', 1 0' was unaffected. These changes in 
chemical shift values confirm the formation of amantadine ,B-cyclodextrin inclUSIOn 
comple 
The chenucal sh ifts of amantadme and its ,B-cyclodextrin complex are reported m 
Table 3.2 and 33, respectIvely. Inclusion of amantadme into ,B-cyclodextrin cavity 
results m upfield sh ifts of a l l  cyclodextrin signals. F igur'e 3. 1 8  shows the proposed 
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Figure 3.1 7. I H_NMR spectra of: (a )  Amantadine; (b)  Amantadine ,B-cyclodextrin 
mclUSlOn complex; (c) ,B-cyclodextrm m DMSO-� 
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Table 3.2 : l H-NMR chemical shift correspondmg to amantadme and amantadme [J-
c c10dextnn mclu Ion comple 
H - Type 
N Hl 
H-3',S ',7 '  
H-2',8 ', 1 0 '  
H-4',6',9' 
Amantad ine fr·ee 
( 5 ppm)  
8 . 1 7  (s,2 H)  
2 06 (s,3 H)  
1 80 (s,6H) 
1 60 (m,6H)  
Amantadine [J-
cyclodextrin 
I nclusion Complex 
(5 ppm)  
8.08 (s,2H)  
2 . 1 0  (s,3 H)  
1 . 80 (s,6H) 
1 6S (m,6H) 






Table 33: I H_NMR chemical shift correspondmg to free [J-cyclodextrin and amantadme 
[J-cyclodextrin mcluslOn complex. 
[J-cyclodextrin Amantadine fJ-
H - Type free 
cyclodextrin !!.5B Inclusion Complex 
( 5 p p m )  ( 5 ppm)  
H- 1 4 82 (s, I H) 4 .82 (s, l H) 0 
H-3 3 . 64 (s, l H) 3 .63 (s, l H) -0.03 
H-6,6' 3 .64 (s,2H )  3 63 (s,2H)  -0 0 1  
H-S 3 . S6 (m, l H )  3 . S4 (m, l H ) -0.02 
H-4 3 .43 (m 1 H ) 3 .36 (s, l H)  -0.07 
H-2 3 .29 (m, l H) 3 . 36 (s, l H ) 0 07 
a PositIve and negative signs show downfield and upfield shIfts, respectively 
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( a ) ( b )  
Figure 3. 1 8  Proposed scheme for the mciuslOn complex formation between amantadme 
(a )  and �cyclodextrm ( b ). 
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3.6.2. I H_ M R  tudy of 2-Anthraq uinonyl amantad ine P.cyclodextrin inclusion 
com plex 
The I H_NMR spectrum of 2-Anthraqumonyl amantadme IS shown in Figure 3. 1 9A 
The harp mglet signal at 8 8 53 ppm can be assigned to the H- l ' proton, whI le  the 
multiplet signal at 8 7 95 ppm can be attnbuted to the H-3 '  and H-4' of the antraqumone 
protons The anthraqumone protons H-5 ',6' ,7' and 8' were shifted upfield and appeared 
as doublet (1=7 Hz) at 8 8  22 ppm. The ahphauc protons of amantadme resonate as two 
harp smglet signals at 8 2. 1 1  and 8 1  68 ppm 
The formatIOn of 2-Anthraqumonyl amantadine P.cyclodextrin inclusion complex 
(F igUl'es 3 . 19B)  resulted in small chemical shifts of 2-Anthraquinonyl amantadine 
protons. The H- l '  signal of anthraquinone remained unchanged while the NH shIfted 
downfield b 118 = 0 .06 ppm. The s ignals of the other antraquinone protons were also 
sl Ightly shifted downfield These observations confirm the formation of the 2-
Anthraqumonyl amantadine p..cyclodextrin inclusion complex with a partial or complete 
mclusion into the P.cyclodextnn cavity. Upon inclusion complex formation of 2-
Anthraqumonyl amantadme With p..cyclodextrin, the H-3 signal of P.cyclodextrin 
remamed unchanged whereas the H-5 signal was shifted downfield by 118 = 0.03 ppm. 
On the other hand, the two protons H-6,6' remained unchanged. In addition, the H-2 
pattern of the P.cyclodextrin has changed from multiplet to singlet with an upfi led shift 
8= 0 04 ppm 
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The chemical sh ift for both 2-Anthraqumonyl amantadme and It 'S j3-cycJode tnn 
comple are hown in Table 3.4 and 3.5, respectively Figure 3.20 shows the expected 
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Figure 3. 1 9. I H_NMR spectra of: (a )  2-Anthraquinonyl amantadme; ( b) 2-
Anthraqumonyl amantadme ,B-cyclodextrin inclusion complex; ( c )  ,B-cyclodextrin in 
DMSO-d6. 
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Table3.4: l H_ MR chemIcal shIft correspondmg to 2-Anthraqumonyl amantadine and 2-
nthraqumon I amantadme ,8-cyclodextnn mc\uslOn comple 
2-Anthraqu inonyl 2-Anthraquinonyl 
H - Type amantad ine f."ee amantad ine ,8-cyclodextrin 1181i 
(8 ppm) Inclusion Complex (8 ppm} 
H- l '  8 .53  (s, l H) 8 .53 (d, I H, J=1 .2 Hz) 0 
H- ',6 ',7 ',8 '  8 22 (d,4H,J=7 Hz) 8 .23 (d,4H, J=6 2 Hz) 0 0 1 
NH 8 . 1 7  (s, l H) 8 . 1 1 ( s, I H) -0.06 
H-3 ',4 ' 7.95 (m,2H) 7 96 (m,2H) 0 .0 1  
H-3  ",4",5 ",6",7",9" 2 . 1 1 (s ,3H) 2 . 1 1 (s,2H) 0 
H-2",8", 1 0" 1 68 (s,6H) 1 .68 (s,4H) 0 
8 POSItive and negatlve S lgnS show downfield and upfield shlfts, respectively 
Table 3.5: IH_NMR chemical shift corresponding to free ,8-cyclodextrin and 2-
Anthraquinonyl amantadme ,8- cyclodextrin inclusion complex. 
2-Anth."aquinonyl 
H - Type ,8-cyclodextrin free amantad ine ,8-cyclodextrin 118ft ( 8 ppm) I nclusion complex 
( 8 ppm ) 
H - l  4 .82 ( s, l H ) 4.8 1  (s, I H) -0.0 1  
H-3 3 .64 (s, l H) 3 .64 ( s, I H) 0 
H-6,6' 3 .64 (s,2H) 3 .64 ( s,2H) 0 
H-5 3 . 56 (m, l H) 3 .59 (m, l H ) 0.03 
H-4 3 .43 (m, l H) 3 .53  (s, I H) 0. 1 
H-2 3 .29 (m, l H) 3 . 33  (s, l H) 0.04 
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Figure 3.20. Proposed scheme for the inclusion complex formation between (a )  2-
Anthraqumonyl amantadme and J3-cyclodextnn ( b) .  
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3.6.3. I H _  M R  tudy o f  acyclovir �cyclodextrin inclusion complex 
Figur'e 3.2 1 A  shows the I H_ MR spectrum of acyclovir. The NH2 protons appear as 
a mglet s ignal at 8 6  5 1  ppm The NH of the punne nng IS centered at 8 4.69 ppm as a 
smglet The H-8' proton of the punne rmg resonates as a doublet at 8 7.82 ppm The H-
1 0' of the [(2-h droxy-etho y) methyl ] protons appeared at 8 5 3 5  (s), wh ile H- l 1 '  and H-
1 2' protons appeared at 8 3 .47 (s). These values are very close to those previously 
reported b Rossel et al [5 1 ]  
Figure 3.2 1 B  shows the IH_NMR spectrum of acyclovir �cyclodextrm inclUS iOn 
comple The differences in chemical shift val ues between acyclovir and It 'S � 
cyclodextnn complex show upfield and downfield shifts. The H-8' and NH protons of 
the punne flng show an upfield shift of 0 .0 1  ppm and appear at as 8 7.8 1 (s) and 8 4.70 
(s), respectively The h ighest difference (0.06 ppm) was observed on H- l 1 '  proton and H-
1 2' proton of the [(2-hydroxy-ethoxy) methyl ]  protons which appeared as doublet at 8 
3 53 ppm The other protons of the acyclovir molecule showed upfield shifts of about 118 
0.0 1 ppm Tables 3.6 and 3.7 show the I H_NMR chemical shift values of acyclovir and 
its �cyclodextrin complex 
Upon mclusion complex formatIOn between acyclOVir and �cycJodextrin, the H-3 
and H-6,6 '  protons s ignals of �cyclodextrin were sifted upfield by 118 == 0.0 1 ppm. The 
H-2, H-4 and H-5  protons s ignals were shifted downfield by 118 == 0.04 ppm, 118 == 0 02 
ppm and 118 == 0.03 ppm, respectively (Tables 3.6 and 3.7 ) 
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These ob ervatJons 10 chemIcal shIfts confirm the formation of acyclo Lr f3-
c c10de tnn inclusion comple The hIghest difference observed for the H-l 1 '  and H- 1 2' 
proton of the [(2-hydroxy-ethoxy) meth I ]  reS Idue was due to the complete mclusion of 
the [(2-h droxy-ethoxy) methyl ]  reSIdue inside the {3-cyclodextrin cavity [53 ]  The 
e pected formatIon mechamsm of acyclovIr f3-cyclodextrin inclusion complex IS shown 
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Figure 3.2 1 .  I H  - NMR spectra of (a )  acyclovir; (b)  acyclovir j3-cyclodextrin mcluslOn 
complex, (c )  j3-cyclodextnn m DMSO-d6 
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Tab le 3.6 I H_NMR chemical sh ift correspondmg to acyclovir and acyclo I f  f3-
cyclode tnn mcluslon comple 
Acyclovil· f3-
H - Type cyclov ir f.·ee cyclodextrin I nclusion 6.58 ( 5 ppm)  Complex 
(5 ppm)  
OH 1 0.65 (s, I H) 1 0 64 (s, I H) -0 0 1  
H-8 '  7 82 (d,  I H, J=O 8 Hz) 7.8 1  (d, 1 H,J= l 6 Hz) -0. 0 1  
NH2 6 .5 1 (s, 2H) 6 .50 (s ,  2H) -0 0 1  
H- I O' 5 . 3 5  (s, 2H)  5 .34 (s ,  2H)  -0 0 1  
NH 4.69 (s, I H) 4 .70 (s, I H ) -0 0 1  
H- l l '  3 47 (s, 2H) 3 . 53 (d, 2H,J=4 6 Hz) 0 06 
H - L' 3 .47 (s, 2H) 3 53 (d, 2H,J=4 6 Hz) 0 06 
8 Positive and negative S Igns show downfield and upfield shifts, respectively 
Table 3.7 I H_NMR chemical sh ift corresponding to f3-cyclodextrin and acyclOVIr f3-
c clodextnn mcluslOn complex 
Acyclovir f3-
H - Type ,B-cyclodextrin free cyclodextrin Inclusion 6.5 8 
( 5 ppm)  Complex 
( 5 ppm) 
H- l 4 .82 (s, I H) 4 .82 (s, I H) 0 
H-3 3 .64 (s, l H) 3 .63 (s, I H) -0 0 1  
H-6,6' 3 .64 (s,2H)  3 63 (s, 2H)  -0.0 1  
H-5  3 . 56 (m, I H) 3 .59 (s, I H) 0 03 
H-4 3 43 (m, l H) 3 .46 (s, I H ) 0.02 
H-2 3 .29 (m, l H) 3 .33 (d, 1 H,J= 8 .6 Hz) 0.04 
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Figure 3.22. Proposed scheme for the incluslOn complex formation between (a ) 
Acyclo I r  and P-cyclodextrin ( b )  
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3.6.4. ' H - M R  tudy of 2-N-benzoy l acyclovir ,B-cyclodextrin inclusion complex 
Figure 3.23A shows the ' H-NMR spectrum of the 2-N-benzoyl acyclovir. The OH 
proton appears as a s inglet at 8 1 2  36 ppm. The NHCO proton s Ignal is centered at 8 
1 2 02 ppm as broad smglet Phenyl protons are resonatmg at 7 60-8 .05 ppm as multip let 
The H- I O' of the [(_-h dro y-ethoxy) methyl ]  protons appeared 8 5 .52 (s), whtle H- l 1 '  
and H- 1 2 ' protons appeared at 8 3 .49 (d, 4 H, J= 8 .2 Hz) 
Formabon of 2- -benzo I ac clovir ,B-cyclodextrin mcluslOn complex resulted In 
some proton s Ignals of both guest and host to be shIfted eIther upfield or downfield 
( Figure 3.23B) The difference ill chemIcal shift alues between 2-N-benzoyl acyc lovlf 
and ItS ,B-cyc lodextrin complex shows that protons of the phenyl group are shIfted by 
0 03 ppm (Ta ble 3.8) The hIghest dIfference (�8 2 04 ppm) was observed for H- l 1 '  and 
H- 1 2' of the [(2-hydroxy-ethoxy) methyl] protons. The H-8' proton of the punne f1ng 
shows an upfield shIft by 0 0 1  ppm and appears as doublet at 8 8. 1 7  ppm (J= 1 .2 Hz) . On 
the other hand, Table 3.9 shows that the H-3 and H-6,6' proton signals of ,B-cyclodextrin 
were sh ifted up field by �8 == 0 0 1  ppm. The H-5 and H-2 were shifted downfield by �8 
== 0.03 ppm and 0.04 ppm, respectively 
The differences observed m chemical sh ifts indicate that the phenyl group and [ (2-
hydroxy-ethoxy) methyl ]  res Idue are tota l ly located insIde the ,B-cyclodextrin cavIty [53 ] 
Figure 3.24 shows the proposed mechanism of the formatIOn of the 2-N-benzoyl 
acyclOVir ,B-cyclodextrin mcluslOn complex 
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Figure 3.23 ' H_NMR spectra of (a )  2-N-benzoyl acyclovir; ( b) 2-N-benzoyl acyclovIr 
,B-cyclodextrm mclusIOn complex, (c) ,B-cyclodextnn In DMSO-d6_ 
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Table 3.8 : I H_NMR chemIcal shIft correspondtng to 2-N-benzoyl acyclovIr and 2- -
benzo l ac clo Ir .,&cyclodextnn mcluslon comple 
2-N-benzoyl acyclovir 2-N-benzoyl acyclovir .,& 
H - Type f,·ee cyc lodextrin I nc lusion 
( 8 ppm)  Complex 
8 
H-8' 8 1 8 (d, I H, J=1 4 Hz) 8 1 7 (d, I H, J=1 2 Hz) 
H- l "  8 05 (d, 2H, J=7 Hz) 8 .04 (t, 2H, J=4 2 Hz) 
H-2" 7 60 (m, 3H)  7. 58 (m, 3H)  
H- I 0' 5 . 52 (s, 2H) 5 52 (s, 2H ) 
H- l 1  ' 3 49 (d, 2 H, J=8.2 Hz) 5 . 53 (s, 2H) 
H - 1 2' 3 49 (d, 2H, J=8 2 Hz) 5 . 53 (s, 2H)  
8 POSIt! e and negatl e S IgnS show downfield and upfield shills, respectively 
-0 0 1  





Table 3.9: I H_NMR chemical shjft correspondmg to .,&cyclodextrin and 2-N-benzoyl 
acyclovir .,&CD mcluslOn complex 
2-N-benzoyl acyclov ir .,& 
H - Type .,&cyclodextrin free cyclodextrin I nclusion !l88 ( 8 ppm)  Complex 
(8ppm) 
H- 1 4 82 (s, I H) 4.82 (5, I H ) 0 
H-3 3 .64 (s, I H ) 3 63 (5, I H) -0. 0 1  
H-6,6' 3 64 (s,2H)  3 .63 (s, 2H) -0.0 1  
H-5 3 56 (m, l H ) 3 .59 (5, I H) 0.03 
H-4 3 .43 (m, l H) 3 .43 (5, I H ) 0 
H-2 3 .29 (m, I H) 3 .33  (m, I H) 0.04 
8 PosItive and negative S IgnS show downfield and upfield shifts, respectively 
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Figure 3.24. Proposed scheme for the mclusion complex formation between : (a) 2-N-
benzoyl acyclovlr, and ,B-cyclodextrin . 
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3.7. Quan ti tative MR tud ie 
3.7. 1 .  toichiometry o f  the inclusion complexes 
The stolch lometn es  of the mcluslOn complexes of ,B-cyclodextnn WIth amantadme, 2-
Anthraqumon 1 amantadme, acyclo I r  and 2-N-benzoyl acyclovir were determmed usmg 
the molar rat io method based on samples with vanous host/guest ratios as descnbed m 
the e penmenta l  sectton lH-NMR spectra obtained were evaluated and drug',B­
c clode tnn stoichIOmetry was calculated using graphical representations of �5. versus 
R, where R IS the host/guest molar ratio ( [,8-cyclodextnn]/[Guest] ), and �5. IS the 
chemIcal shift of selected protons relative to the chemical sh Ift of the ,B-cyclodextrm 
anomenc proton (H- l )  10 the l H_NMR measurements. 
The ,B-cyclodextn n  anomenc proton (H- l ) was used as an internal reference 
throughout the stoichIometric calculation This is due to ItS location which ensures the 
smallest mduced chemical shift  and thus H- l IS less affected by the complexatIOn. 
Another reason IS that the ,B-cyclodextrin outer protons can be affected by the 
comple atlOn smce they are near the rims [52,5 3 ] .  
Figure 3.25 shows the I H-NMR spectra usmg different molar ratios between 
amantadme hydrochloride and ,B-cyclodextrin.  Upon form 109 the inclusion complex, the 
mtenslties of amantadme hydrochloride signals were reduced. Changes in chemical sh ifts 
of ,B-cyclodextnn inner protons and amantadine hydrochloride H-3',5 ',7'  protons with 
host/guest (,B-CD/drug) molar ratlos are shown in Figure 3.26A and 3.26B, respectlvel 
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The rna 1mum change m chemical sh ifts occurs at an R value of 1 ,  mdlcatmg a l l  
stoich iometry for the mcluslon complex These results are consistent Wlth prevlOusl 
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Figure 3.25: I H_NMR spectra using d ifferent molar ratios between amantadine and fJ-
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Figure 3.26: Analysis of I H-NMR data for amantadine ,B-cyclodextrin mclus lOn 
complex: A) Plot of 6£}. for the ,B-cyclodextrin inner protons; B) P lot of data 
corresponding to amantadine H-3',5',7' protons. The values on the x-axis correspond to 
Host/Guest RatIO ( R) 
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Figure 3.27 shows the IH_NMR spectra upon add ItIon of dtfferent amounts of � 
c clode tnn to 2-Anthraqumonyl amantadme. Upon forming the mclusion complex, the 
mtenslt1e of 2-Anthraqumonyl amantadine SIgnals were reduced. Changes in chemIcal 
htft ( �) of �c clodextrm mner protons and the phenyl rmg protons of 2-
Anthraqumon I amantadme are shown in Figure 3.28A and 3.28 B, respectIvely The 
maxImum change m chemical shift of cyclodextnn protons occurs at an R value of 1 ,  
mdlcatmg the presence of one molecule of 2-Anthraqumonyl amantadine. Guest protons 
show an R alue of 2, mdlcatmg more than one cyclodextnn (host) molecule for each 2-
Anthraqumonyl amantadine (guest) These facts confirm the formation of a 2-









Figure 3.27: I H_NMR spectra upon addition of different amount of ,B-cyclodextrin to 2-
Anthraqumonyl amantad ine [Host/Guest] ratios: (a) 0. 33 ,  (b) 0.67; (c) 1 ;  (d) 1 69, (e)  2 
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Figure 3.28: Analysis of I H-NMR data for 2-Anthraquinonyl amantadine p-cyclode tnn 
inclus Ion complex: A) Plot of L15, for the p-cyclodextrin inner protons; B)  Plot of data 
correspondmg to the phenyl nng of 2-Anthraquinonyl amantadme protons. The values 
on the x-axIs correspond to Host/Guest Ratio (R)  
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hown In Figure 3.29 IS the I H_NMR spectra upon additlOn of dIfferent amounts of 
� clodextnn to ac clo Ir pon forrmng the incluSIOn complex, the intenSItIes of 
ac c lo Ir Ignals were reduced tOlchiometry of acyclovIr ,B-cyclodextrm inclusIOn 
comple was In esttgated b measunng the vanatlOns in chemical shifts of � 
cyclodextnn mner protons and acyclo ir H -8 '  proton WIth changmg the acyclovlrl� 
c clodextnn molar ratio Figure 3.30A and 3.30B shows the molar ratIo curve for 
ac clo Ir ersus �cyclodextrm inner protons and acyclovlf H-8' proton, respectively 
The rna Imum change m chemical sh ifts occurs at an R value of 1 ,  indicatmg a 1 1 
stOIchIOmetry for the mcluslOn complex. This IS In  accordance with previously reported 
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Figure 3.29. I H_NMR spectra upon addition of different amounts of ,B-cyclodextrin to 
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Figure 330: Analys is of ' H-NMR data for acyclovir ,B-cyclodextrin incluslOn complex: 
A) P lot of �bi for the ,B-cyclodextnn inner protons; B) Plot of data corresponding t
o H-8' 
acyclovIr proton. The values on the x-axis correspond to Host/Guest Ratio (R
) .  
85  
The I H_NMR spectra upon addItIOns of different amounts of ,8-cyclodextnn to 2- -
benzo I ac clovlr (2- -BAC ) IS shown m Figu " e  3.3 1 .  Upon forming the mcluSlOn 
comple the mtenslties of 2- -benzo I acyclovir signals were reduced Molar ratio plot 
of (P.c clodextnnl2- -BAC ) versus chemical sh ifts of ,8-cyclodextnn Inner protons 
gl es a rna Imum change m chemica l  shifts of cyclodextnn protons at an R value of 1 ,  
Indicating the presence of one molecule of 2-N-benzoyl acyclovir  ( Figure 3.32A). The 
plot of (,8-cyclode trin/2-N-BACV) molar ratio versus chemical sh ifts of the phenyl ring 
of 2- -benzo I acyclovir molecule resu lted in 1 . 1 and 1 ·2 stO ichiometry ( Figu re 332 B) 
The appearance of 1 1 and 1 .2 stOichiometry indicates that the formatIOn of 2-N-benzoyl 
ac clo Ir ,8-cyclodextrm inclusion complex IS due to a stepwise equi l ibrium mechamsm 
as fol lows 
2- - B AC + ,8-CD 
2- - BAC �-CD + ,8-CD 
N-BACV: ,8-CD 
N-BACV: (,8-CD)2 
These results confirm that the inclusion of 2-N-benzoyl acyclovir into the cavity ,8-
cyclodextnn occurs with a predommant stoichiometry ratio of 1 :2 .  
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Figure 3.3 1 I H-NMR spectra upon addition of different amounts of ,B-cyclodextrin to 2-
N-benzoyl acyclovir. [Host/Guest] ratios: (a )  0 1 7; ( b )  0 58 ;  (c) 1 00; (d ) 2.05, (e)  2 . 1 8  
87 
1 29  
1 28 
1 27 









2.94 t.O i 
2.92 
2 9  
2.88 
2 86 
0 0 5  R 1 5 2 2 5  
FigUl'e 3.32:  Ana lysis of I H_NMR data for 2-N-benzoyl acyclovir ,8-cyclodextrin 
mcluslon complex: A) Plot of t.� for the ,8-cyclodextrin mner protons; B) Plot of data 
correspondmg to phenyl nng of 2-N-benzoyl acyclovlf molecu le. The values on the x-
axiS correspond to Host/Guest RatiO ( R ). 
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3.7.2.  Determination of formation constants of the inclusion complexe 
The l H-NMR spectra obtained by measuring series of Jkyclodextrm With each of 
amantadine, 2-Anthraqulnonyl amantadme, acyclovir  and 2-N-benzoyl acyclovir at 
different concentratIOn ratios were used to calculate the formation constants of the 
Inclu Ion complexes based on the Benesi-Ht ldebrand equation modified for NMR 
appl tcatlon [49] 
1 
------- = + ----------- (4) 
�Ima:" Kf [P-CD] n 
where �CD] IS the Jkyclodextrin concentration, M IS the dtfference between the 
integration of the H-3', 5',7' proton for amantadine ,B-cyclodextrin, 2-Anthraquinonyl 
amantadme ,B-cyclodextnn inclUSion complexes as wel l  as H-8' for acyclocvlr ,B-
c clodextnn and 2- -benzoyl acyclovir ,B-cyclodextnn mcluslOn complexes and that of 
each pure drug, Mma.'( is the difference between the integration of the inclusion complex 
and that of pure drug at equihbnum and n represents the stoichiometry of the equihbrium 
reactlon In relatIOn to ,B-cyclodextnn 
The Ka values were estimated from the plots of 1 1M versus 1 /�CD] n ( Figures 3.33 
and 3.34) Linear plots with a slope of 1 /(K Mmax) and intercept of I /Mma.'( were 
obtamed Formation constants values (Kf) were estimated from the ratio between the 
Intercept and the slope. A 1 · 1 stoichIOmetry was obtained for amantadine ,B-cyclodextrm 
and acyclovir ,B-cyclodextrin, inclUSIOn complexes (F igur·es 3.33A and 3.33B) . A 1 :2 
89 
stOIchiometry was obtatned for 2-Anthraqumonyl arnantadme ,B-cyclodextrin and 2- -
benzo I ac clo I r  fJ-c clodextnn incluSion complexes ( FigUl'es 3.34A and 3.34B) 
90 
A 
0 1 4 
0. 1 2  
0 1  
"<1 0 08  --... 















0 20 � 00 l I[P-CDI 
80 1 00  
o W � 00 � 1 00  1 W  1 �  1 00  
1 /[P-CD] 
Figure 3.33 : Graph of 1 1M versus 1 /[ft-CD] according to Eq. (4) for .  (A) Amantadine � 
cyclodextnn incluSion complex; (B)  Acyclovir �cyclodextrin inclusion complex 
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Figure 3.34: Graph of 1 1M versus. 1 /[,B-CD]2 according to Eq. (4 )  for'  A) 2-
Anthraqumonyl amantadine ,B-cyclodextrin inclusion complex, B)  2-N-Benzoyl acyclovir 
,B-cyclodextnn inclusIOn complex 
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The Kr al ues of 3 1 
c c10dextnn and ac clo I r  �c clodextnn 1 1 mcluSlOn comple es were obtained. 2-
Anthraqumon I amantadme �cyclodextnn and 2-N-benzoyl acyclovir �cyclodextnn 1 ·2 
mclus lon complexes ga e Kr alues of 3 .2  1 04 mor2 L2 and 5 .9  x 1 02 mor2 L2 at room 
temperature (Table 3.1 0 ). 
The h igher affintty of the �cyclode tnn by 2-Anthraqumonyl amantadme and 2- -
benzo I ac clo I r  cou ld be due to the increase of the degree of the 2-Anthraqumonyl 
amantadme and 2-N-benzoyl acyclovir hydrophobicity after denvatizatlOn. Th is might 
pro Ide stabtl ization for the 2-Anthraquinonyl amantadine �cyclodextrin and 2-N­
benzoyl ac c10vlr �cyclodextrin 1 · 2 mclusion complex 
The Kf values obtamed by I H _NMR are relatively smal ler than prevIous values 
obtamed usmg UV-VIS spectrophotometer (fa ble 3 . 1 ). The reason might be due to the 
higher sens lti tty of UV-Vis method compared to IH _NMR method However, different 
affinity order for the 2-Anthraquinonyl amantadine �cyclodextnn and 2-N-benzoyl 
acyclovlf �cyclodextrm mclusion complexes was obtained with the UV -Vis method 
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Table 3. 1 0: Formation constants of the p-cyclodextrin mcluslOn complexes using IH_ 
NMR. 
tochiometry Kf The linear regress ion equations 
Amantadine 
p-c c10dextnn 1 : 1 3 1 x 1 0 l mori L I Y = 8 6 1  E-04X + 2.67E-02 inclus IOn complex 
Ac clo I f  
p- c c10de trm 1 : 1 4 .3 x 1 01 mOrl L I Y = 4.49E-04X + 1 . 9 1 E-02 mclus lon complex 
2- -benzo I 
acyclovir p-
c c10dextrin 1 :2 5 .9  x 1 02 mor2 L2 Y = 5 . 84E-05X + 3 . 43E-02 
inclus IOn comple 
2-AnthraquLflonyl 
am an tadine p- 1 ·2 3 .2  x 1 04 mor2 L2 Y = 2 1 3E-06X + 6.83E-02 
cyclodextrin 







3.7.3. Quanti tative analysis of a mantad ine hydrochloride and acyclovir 
To pro Ide quantltatl e mformatlOn for the amantadine hydroch loride and acyclovIr 
a sa , ample preparatlOn and NMR data col lectIon parameters were 0pt lmlZed. DMSO­
d6 was u ed a sol ent to lock the field frequency and to 0 ercome the preclpitatton of 
ac clo Ir in D20 Howe er, preparatIon and separation procedure wI l l  be required to 
anal ze p lasma samples NMR spectra were measured uSing a flip angle of 45° and a 
dela time of 1 s associated WIth an acqUIsitIOn time of 1 99 s. The number of 
transIents/scans was preset at 200 to achieve optimal signal-to-noise ratIo �5 
Malontc aCid was used as an mtemal standard because Its IH_NMR signal does not 
overlap WIth an of the amantadme hydrochlonde and acyclovir peaks in the spectrum. It 
is also soluble and stable m sample media and is available in high punty. Signals at t5 
2.07 ppm for amantadme hydrochloride and t5 7 . 82 ppm for acyclovir were Integrated 
relatl e to that of the mtegral of malonic acid at t5 3 . 24 ppm and used in calculating the 
amounts of both drugs under investigation 
The I H_NMR spectra of amantadine hydrochlonde and acyclOVir showed 
symmetncal and wel l  separated signals. Figures 335 and 3.36 show the spectra of a 
mo,ture of amantadine hydrochloride ( 1 0  mg) and acyclOVir ( 1 0  mg) with malon ic acid 
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Figure 3.36. I H_NMR spectrum of acyclovir (1 0 mg) with malol1lc aCid ( 1 0 mg) 
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_A 
'2 I' Plil 
CalIbrat ion graphs for amantadme hydrochlonde and acyclo ir were determmed b 
te tmg a concentratIOn senes of each drug with malomc aCid as an internal standard 
Intens ity as well  as sIgnals areas mcreased by mcreasmg the concentratIOn The area of the 
selected s Ignal of amantadme hydrochloride and acyclovir at 0 2 07 and 0 7 82 ppm were 
plotted versus normalized signal area (R)  of the drug amounts m mil ligrams. Linear graphs 
m the range of 0 75- 1 5 3 mg and 0.45 -50 mg were obtained for amantadine hydrochloride 
and ac clo Jr, respectl ely ( Figure 337).  Lower quantificatIOn I tmlts (QL) of 0 .75 and 0.45 
mg were Imposed b the sensitivity of the NMR spectrometer detectIOn for amantadine 
h droch londe and acyclovir, respectlVely The upper quantification l irmts of 1 5 . 3  mg and 50 
mg were imposed by the saturation l imIts of both drugs m 0.6 ml DMSO-d6. CorrelatIOn 
coefficients of 0 998 and 0 997 for amantadme hydroch loride and acyclovir, respectively, 
Indicate an excel lent I Lnear correlation Table 3. 1 1 summarizes the lmear ranges l inear 
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Figure 337. Normal ized area vs. mi l l igram amounts of: (A )  amantadine hydroch londe; (B)  
acyc lovlI calIbration graph.  
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Table 3 . 1 1 :  Lmear ranges, regresslOn equatlOns and correlatiOn coefficient of amantadme 
hydroch londe and acyclovir cahbratlon curves 
Analyte Linear range (mg) Regression equation a Correlation coefficient (R2)  
Amantadme 0 76 - 1 5 . 3  R =3 . 7 1  07 W + 36.3 55 0.998 hydrochloride 
Acyclo ir 0.45 - 50 R = 1 . 3 1 86 W + 2.5564 0.998 
a R = ( 1  I I ) WI , where. 
1 IS  the integratiOn of a specific signal of each drug 
l IS IS the mtegratiOn of a specific signal of malonic acid and. 
WI IS the molecular weight of the internal standard (malonic aCid). 
a W IS the weigh of amantadine hydroch loride and acyclovlf in mg. 
1 00 
3.7.4. Quantita tive aDaly is of pha rmaceutical samples 
The developed NMR methods were used for the determmatlOn of amantadme 
h droch londe and acyclo Ir In the commercial ly available pharmaceutical preparatlOns 
Table 3. 1 2  descnbes the results of the I H_NMR method app lied to the determmatlOn of 
amantadme h droch londe and acyclovir m Adamme capsules and Zovirax tablets, 
re pecttvel 
respectJ el 
Average recoveries of 98 24- 1 00 40% and 97 70-98 80% were obtamed, 
The results were statlstical ly evaluated usmg Student t-test Average t- alues :::; 0.72 and 
:::; 1 73 for amantadme hydrochloride and acyclovir, respectively, indicate insignificant 
difference in accuracy between the measured and the assigned values for amantadme 
h drochlonde and acyclOVir at a 95% confidence level (fable 3 . 1 2 ). 
The dlfference in preCiSlon between the IH_NMR developed method and those obtained 
by HPLC methods was tested by applying the F-test [57,58]  F-values of :::; 0 .50 and :::; 6 .82 
for amantadme hydrochlonde and acyclovir, respectively, indicate insignificant difference in 
prec IS Ion between the calculated and theoretical values of both the I H_NMR de eloped 
method and the HPLC reported method at a 95% confidence level (Table 3. 1 2 ). 
1 0 1  
Ta ble 3. 1 2 : Re ults of assa of amantadme hydrochloride and acyclo Ir in pharmaceutical 
preparatIOns b the proposed I H_NMR method 
mg Taken a mg Found Recovery % SD RSD % t-Value F-Value 
Adamme capsule b 
6 07 6 .02 99. 1 7  % 0. 1 8  2 .99 % 
7 44 7 47 1 00 .40 % 0 26 3 .48 % 
8 03 7 88 98 .24 % 0.36 4 57 0/0 
Zo Ira tabletsC 
5 4  5 34 98.80 % 0 . 1 0  1 .8 1  % 
9 1 8  9 02 98 .25 % 0 1 6 1 .77 % 
1 5 29 1 4.94 97.70 % 0.53 3 54 %  
a A erage of at least three determinations 
b Adamme capsules containing 1 00 mg of amantadine hydroch londe. 




1 . 04 
1 . 73 
1 . 1 4  
d F-values for amanadine hydroch loride and acyc lovir based on S D  values of our NMR 
method and H PLC method [ 57,58] 
1 02 
0. 1 2  
0.28 
0 50 




3.7.5. Quanti ta tive analysis of pia rna sample 
The proposed NMR methods were further val idated by determinatlOn of amantadine 
h droch londe and acyclo Ir m human plasma Signals at 0 2.07 ppm for amantadine 
h dro h londe and 0 7 82 ppm for acyclovir were mtegrated and the correspondmg 
concentratIOns were calcu lated us10g the cal ibratIOn graphs regresSIOn given 10 Table 3.1 1 .  
The results revealed average recovenes 10 the range of 97 36-1 03 .68 % and 96. 5 1 -99.80 
0'0 With a tandard deviatIOn m the range of 0.20-{) 45 and 0 1 3 -0.72 for amantadine 
hydroch londe or acyclovir, respectively (Table 3. 1 3). Student's t-values in the range of 
1 00-1 73 and 0 06-2. 40 for amantadine  hydrochloride and acyclovir, respectively, indicate 
IOs lgntficant difference 10 accuracy between the measured and real values at 95% confidence 
Ie el (Table 3. 1 3 )  
Precision o f  the I H_NMR developed method was also compared With the results obtamed 
from the H PLC reported methods [59,60] by applying the F-test. F-values of � 2 .58  and � 
2.37 for amantadme hydrochloride and acyclovir, respectively, show that the IH-NMR 
method IS comparable m precIS ion to the reference method and there is no significant 
difference between the calculated and theoretical values of both methods at a 95% 
confidence level (Table 3. 1 3 )  
1 03 
Table 3.1 3: Re ults of assay of amantadine hydrochloride and acyclovir in human plasma 
ample b the proposed IH _NMR method 
mg Taken a mg Found Recovery % 
Amantadine hydroch lorIde b 
5 . 3  5 5  1 03 .68 % 
1 0 . 1  9 84 97.36 % 
Acyclo I r 
5 . 1 4 92 96.5 1 % 
1 3 . 1 5  1 3  1 2  99.80 % 
a A erage of at least three determlnatlOns 
SD RSD % t-Value F-Value d 
0.2 3 .72 % 1 . 73 2 .58 
0 45 4 59 0'0 1 00 1 .63 
0 . 1 3  2 .69 % 2.40 2 .37 
0.72 5 .45 % 0 06 1 . 85  
d F-values .  for amantadine hydrochloride and acyclovir based on SD values of our NMR 




4. onelu ion 
everal conclusions that could be drawn from the present work are as follow 
( I ) Absorption measurements have demonstrated the mcluslOn complexation interaction 
between 2-Anthraqumon I amantadme, 2-N-benzoyl acyclovir guests and ,B-cyclodextrin 
( 1 1 ) The l H_NMR is a useful techn ique to study the inclusion behavior between � 
cyclodextnn and amantadme, 2-Anthraqumonyl amantadme, acyclovir and 2-N-benzoyl 
ac clo Ir guests 
( 1 1 \ )  The stoichlometnc and the formation constants (Kr) were evaluated by lH _NMR 
observatIOns Spectral chemical shifts suggest the formation of 1 : 1  inclusion complex for 
amantadme and acyclovir' and a 1 :2 inclusion complex for 2-Anthraquinonyl amantadme 
and 2-N-benzoyl acyclOVir with �cyclodextrin.  The Kr obtained by lH_NMR are 
relatively smal ler than those obtained using UV-Vis spectrophotometer. This is because 
DMSO-d6 used in the analysis competes with both derivatized compounds (2-
Anthraquinonyl amantadine and 2-N-benzoyl acyclovir) for a space m the cyclodextnn 
ca lty resulting m a decrease in  the Kr values 
( IV)  The developed l H_NMR method al lowed for simple, precise and selective 
determinatIOn of amantadine hydrochloride and acyclovir in pharmaceuttca l  and human 
plasma samples using malonic acid as an internal standard. Smce l H_NMR quantitative 
analYSIS is recommended as a USP standard technique, the developed methods can be 
recommended as pharmacopeial standard methods. 
1 05 
APPENDIX 
Quantifications of Amantadine Hydrochloride and Acyclovir in 
Pharmaceutical and Plasma using Nuclear Magnetic Resonance 
Spectroscopy 
A. A. Salem 1.  M. Abdou and H. A.  Saleh 
Department of chemistry, Faculty of Science, UAE University, AI-Ain, UAE 
Abstract:  
Rapid, specific and simple methods for determining amantadine hydrochloride and 
acyclovir antiviral drugs in pharmaceutical and plasma samples were developed. The 
methods are based on 1 H-NMR spectroscopy using malonic acid as an internal standard 
and DMSO-d6 as NMR solvent. Integration of NMR signals at 2.07 and 7.82 ppm were 
used for calculating the concentration of amantadine hydrochloride and acyclovir drugs, 
respectively. Malonic acid signal at 3 .24 ppm was used as the reference signal. Average 
recoveries of (98 .24- 1 0 1 .00) ± 4.82% and (97.7- 1 00.38) ± 3 .36 % were obtained for 
amantadme hydrochloride and acyclovir in pharmaceutical (capSUles/tablets) samples, 
respectively. Corresponding recoveries of (97.36- 1 03 .68) ± 2.99 and (93 . 8 1 -99.80) ± 2.93 
were re pectively obtained for analyzed drugs in plasma samples. 
Statistical student-t test gave t values � 1 .4 1  and 0.29 for analyzed pharmaceutical 
and plasma samples. These values indicated insignificant difference between the real 
contents and the measured values at 95% confidence level. Applying the F-test, gave F 
values � 6.44 and 2 . 80 for amantadine hydrochloride and � 6.82 and 3 .86 for acyclovir in 
pharmaceutical and plasma samples, respectively. These F-values indicated insignificant 
differences in precisions between the developed NMR methods and the HPLC methods 
reported for determining both drugs in pharmaceutical and plasma samples. 
Keywords: Amantadine hydrochloride, Acyclovir, Quantitative NMR Analysis, plasma, 
pharmaceutical, Adarnin, Zovirax. 
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